US20140243821A1 - Energy delivery device and methods of use - Google Patents

Energy delivery device and methods of use Download PDF

Info

Publication number
US20140243821A1
US20140243821A1 US14/348,035 US201214348035A US2014243821A1 US 20140243821 A1 US20140243821 A1 US 20140243821A1 US 201214348035 A US201214348035 A US 201214348035A US 2014243821 A1 US2014243821 A1 US 2014243821A1
Authority
US
United States
Prior art keywords
inflatable element
electrode
conductive material
irrigation
assembly
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US14/348,035
Inventor
Amr Salahieh
Jonah Lepak
Emma Leung
John P. Claude
Tom Saul
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Covidien LP
Original Assignee
Maya Medical Inc
Covidien LP
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Maya Medical Inc, Covidien LP filed Critical Maya Medical Inc
Priority to US14/348,035 priority Critical patent/US20140243821A1/en
Publication of US20140243821A1 publication Critical patent/US20140243821A1/en
Assigned to SHIFAMED, LLC reassignment SHIFAMED, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SAUL, TOM, CLAUDE, JOHN P., LEPAK, JONAH, LEUNG, EMMA, SALAHIEH, AMR
Assigned to SHIFAMED HOLDINGS, LLC reassignment SHIFAMED HOLDINGS, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SHIFAMED, LLC
Assigned to MAYA MEDICAL, INC. reassignment MAYA MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SHIFAMED HOLDINGS, LLC
Assigned to COVIDIEN LP reassignment COVIDIEN LP MERGER (SEE DOCUMENT FOR DETAILS). Assignors: MAYA MEDICAL LLC
Assigned to SHIFAMED HOLDINGS, LLC reassignment SHIFAMED HOLDINGS, LLC ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SALAHIEH, AMR, SAUL, TOM
Assigned to MAYA MEDICAL, INC. reassignment MAYA MEDICAL, INC. ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). Assignors: SHIFAMED HOLDINGS, LLC
Assigned to MAYA MEDICAL LLC reassignment MAYA MEDICAL LLC CERTIFICATE OF CONVERSION Assignors: MAYA MEDICAL, INC.
Abandoned legal-status Critical Current

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61NELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
    • A61N1/00Electrotherapy; Circuits therefor
    • A61N1/02Details
    • A61N1/04Electrodes
    • A61N1/05Electrodes for implantation or insertion into the body, e.g. heart electrode
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00005Cooling or heating of the probe or tissue immediately surrounding the probe
    • A61B2018/00011Cooling or heating of the probe or tissue immediately surrounding the probe with fluids
    • A61B2018/00029Cooling or heating of the probe or tissue immediately surrounding the probe with fluids open
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00053Mechanical features of the instrument of device
    • A61B2018/00214Expandable means emitting energy, e.g. by elements carried thereon
    • A61B2018/0022Balloons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00315Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for treatment of particular body parts
    • A61B2018/00434Neural system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00571Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body for achieving a particular surgical effect
    • A61B2018/00577Ablation
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00642Sensing and controlling the application of energy with feedback, i.e. closed loop control
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00696Controlled or regulated parameters
    • A61B2018/00702Power or energy
    • A61B2018/00708Power or energy switching the power on or off
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00815Temperature measured by a thermistor
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B2018/00636Sensing and controlling the application of energy
    • A61B2018/00773Sensed parameters
    • A61B2018/00791Temperature
    • A61B2018/00821Temperature measured by a thermocouple
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B18/00Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body
    • A61B18/04Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating
    • A61B18/12Surgical instruments, devices or methods for transferring non-mechanical forms of energy to or from the body by heating by passing a current through the tissue to be heated, e.g. high-frequency current
    • A61B18/14Probes or electrodes therefor
    • A61B2018/1405Electrodes having a specific shape
    • A61B2018/1435Spiral
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/06Measuring instruments not otherwise provided for
    • A61B2090/064Measuring instruments not otherwise provided for for measuring force, pressure or mechanical tension
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61BDIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3966Radiopaque markers visible in an X-ray image
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10TTECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T29/00Metal working
    • Y10T29/49Method of mechanical manufacture
    • Y10T29/49002Electrical device making
    • Y10T29/49117Conductor or circuit manufacturing
    • Y10T29/49124On flat or curved insulated base, e.g., printed circuit, etc.

Definitions

  • the present disclosure relates generally to medical devices and methods and more particularly to devices and methods for applying radiofrequency energy to tissue.
  • Some medical treatment procedures involve the disruption of a region of tissue.
  • medical treatment procedures include the delivery of energy to disrupt a region of tissue.
  • Radiofrequency (“RF”) energy devices are an example of devices that can be used to perform such medical treatments.
  • Some RF energy devices have a single RF energy element or a plurality of discrete RF energy elements that have to be repeatedly moved within the subject in order to apply sufficient RF energy to the entire region of the tissue. Such RF energy devices may need to be moved within a patient during a given procedure, which can increase the complexity, time, and energy required to perform a given procedure.
  • a phrase in the form “A/B” means A or B.
  • a phrase in the form “A and/or B” means “(A), (B), or (A and B)”.
  • a phrase in the form “at least one of A, B, or C” means “(A), (B), (C), (A and B), (A and C), (B and C), or (A, B and C)”.
  • proximal and distal refer to a direction or a position along a longitudinal axis of a catheter or medical instrument.
  • proximal refers to the end of the catheter or medical instrument closer to the operator
  • distal refers to the end of the catheter or medical instrument closer to the patient.
  • a first point is proximal to a second point if it is closer to the operator end of the catheter or medical instrument than the second point.
  • Fr or F is defined as three times the diameter of a device as measured in mm.
  • a 3 mm diameter catheter is 9 French in diameter.
  • the term “operator” refers to any medical professional (i.e., doctor, surgeon, nurse, or the like) performing a medical procedure involving the use of aspects of the present disclosure described herein.
  • an expandable energy delivery assembly adapted to deliver electrical energy to tissue.
  • the assembly includes an elongate device and an expandable portion.
  • the expandable portion includes an inflatable element, a single helical electrode disposed on the inflatable element, and at least one irrigation aperture within the inflatable element.
  • the inflatable element is secured to the elongate device and the single helical electrode makes between about 0.5 and about 1.5 revolutions around the inflatable element.
  • the at least one irrigation aperture is adapted to allow fluid to flow from within the inflatable element to outside the inflatable element.
  • the single helical electrode may make between about 1 and about 1.25 revolutions around the inflatable element.
  • a conductive material may be disposed on the elongate device proximal to the expandable portion to electrically couple the single helical electrode to an electrical energy source, wherein the conductive material is disposed on substantially the entire elongate device proximal to the expandable portion.
  • An insulation material may be disposed on substantially all of the conductive material on the elongate device.
  • the conductive material and the single helical electrode may form a unitary conductive material without an electrical junction.
  • the conductive material and the helical electrode may be an elastomeric ink.
  • the expandable portion may include a proximal transition section covered with a conductive material that electrically couples the helical electrode and the conductive material on the elongate device.
  • An insulation material may be disposed on the conductive material on the transition shaped section.
  • the inflatable element is a balloon with a substantially cylindrical section, where the single helical electrode is disposed on the substantially cylindrical section. Additionally or alternatively, the at least one irrigation aperture is in the inflatable element, in the helical electrode, and/or adjacent the helical electrode.
  • the elongate device includes an irrigation lumen therein and an irrigation port therein.
  • the irrigation port can be disposed within the inflatable element and can provide fluid communication between the irrigation lumen and the interior of the inflatable element.
  • an expandable energy delivery assembly adapted to deliver energy to tissue.
  • the assembly includes an elongate device and an expandable element secured thereto.
  • the assembly also includes a unitary conductive material disposed on substantially all of the elongate device proximal to the expandable element and on a portion of the expandable element.
  • the unitary conductor being void of an electrical junction.
  • the expandable element may be an inflatable balloon.
  • the conductive material on the expandable element forms a single helix.
  • the expandable element can include a transition portion with the conductive material also being disposed on the transition portion.
  • An insulation material may be disposed over substantially all of the conductive material on the elongate device proximal to the expandable element.
  • the transition portion may include a conically-shaped portion.
  • an expandable energy delivery assembly adapted to deliver energy to tissue
  • an elongate device comprising an irrigation lumen therethrough and an irrigation port proximal to a distal end of the elongate device.
  • An inflatable element is secured to the elongate device such that the irrigation port is disposed within a fluid chamber defined by the inflatable element.
  • An electrode is disposed on the inflatable element and at least one irrigation aperture is provided and adapted to allow fluid to pass from within the fluid chamber to outside the inflatable element.
  • the irrigation aperture is sized to maintain a pressure within the inflatable element between about 0.5 atm and about 4 atm when a substantially constant irrigation flow rate is between about 5 mL/min and about 15 mL/min.
  • the assembly may also include a temperature sensor adapted to measure fluid temperature and may further include an energy source and a controller, the controller being adapted to automatically turn off the energy source if a sensed fluid temperature is above a threshold limit.
  • the temperature sensor can be disposed within the inflatable element.
  • the assembly includes a flow rate sensor adapted to sense fluid flow rate and may further include an energy source and a controller, the controller being adapted to automatically turn off the energy source if a sensed flow rate falls below a minimum value.
  • the assembly may include a pressure sensor adapted to sense fluid pressure and may further include an energy source and a controller, the controller being adapted to automatically turn off the energy source if a sensed pressure falls below a minimum value.
  • a method of manufacturing an expandable energy delivery assembly adapted to deliver energy to tissue includes: providing an inflatable element secured to an elongate device; inflating the inflatable element; and depositing a conductive material on an exterior surface of the inflatable element to form a single helical electrode making between about 0.5 and about 1.5 revolutions around the inflatable element.
  • Depositing may include vapor deposition, electroplating, electroless plating, pad printing, spraying, or ink jet.
  • a mask may be applied to the inflatable element before the depositing step.
  • the depositing step includes depositing the conductive material on substantially all of the elongate device proximal to the inflatable device and on the inflatable element, forming a unitary conductor.
  • the depositing step may also include depositing the conductive material on a conical section of the inflatable element.
  • the mask is removed, a second mask is applied over the helical electrode, and an insulation material is deposited over substantially all of the elongate device proximal to the inflatable element.
  • Depositing the insulation material can include depositing the insulation material over a transition section of the inflatable element.
  • applying the second mask can include applying the second mask over an entire intermediate section of the inflatable element.
  • a method of manufacturing an expandable energy delivery assembly adapted to deliver energy to tissue includes: providing an inflatable element secured to an elongate device; inflating the inflatable element; and depositing a conductive material on the elongate device and a portion of the inflatable element in a single depositing step to form a unitary conductor without an electrical junction.
  • An insulation layer is deposited over the conductive material on the elongate device.
  • the depositing step may include depositing an elastomeric conductive material on the elongate device and a portion of the inflatable element in a single depositing step to form an elastomeric unitary conductor.
  • depositing the conductive material includes depositing the conductive material using vapor deposition, electroplating, electroless plating, pad printing and spraying, or ink jet.
  • a method of providing an irrigation fluid to an inflatable medical device includes: providing an elongate device with an inflatable element secured thereto, the inflatable element defining a fluid chamber and comprising at least one irrigation aperture therein to allow a fluid to flow through the inflatable element, the elongate device comprising an irrigation lumen extending therethrough that provides fluid communication to the inflatable chamber; continuously flowing the fluid at a substantially constant flow rate between about 5 mL/min and about 15 mL/min from a fluid source and into the irrigation lumen while allowing fluid to flow out of the fluid chamber through the at least one irrigation aperture; and maintaining a fluid pressure within the inflatable element between about 0.5 atm and about 4 atm.
  • a method of providing an irrigation fluid to an inflatable medical device includes: providing an elongate device with an inflatable element secured thereto, the inflatable element defining a fluid chamber and comprising at least one irrigation aperture therein to allow a fluid to flow through the inflatable element, the elongate device comprising an irrigation lumen extending therethrough that provides fluid communication to the inflatable chamber; and maintaining a substantially constant pressure between about 0.5 atm and about 4 atm within the inflatable element sufficient to maintain a flow rate of between about 5 mL/min and about 15 mL/min through the inflatable element and out of at least one irrigation aperture
  • a method of delivering RF energy to tissue includes: providing an elongate device with an inflatable element secured thereto, the inflatable element defining a fluid chamber and comprising at least one irrigation aperture therein to allow the fluid to flow through the inflatable element, the elongate device comprising an irrigation lumen extending therethrough that provides fluid communication to the inflatable chamber from a fluid source; continuously flowing a fluid at a substantially constant flow rate from the fluid source; sensing a temperature of the fluid; automatically stopping the delivery of RF energy to an electrode on the inflatable element if the sensed fluid temperature is above a threshold temperature.
  • Sensing a temperature of the fluid may include sensing a temperature of the fluid within the fluid chamber. Delivery of RF energy to an electrode on the inflatable element can be automatically stopped if the sensed fluid temperature is above about 60 degrees C.
  • the method further includes endovascularly positioning the inflatable element within a renal artery, and RF energy is applied through the electrode on the inflatable element to renal nerves to disrupt transmission of neural signals along the renal nerves to treat hypertension.
  • the RF energy may be delivered through a unitary conductor including an electrode that may be, for example, a helically-configured electrode.
  • a method of treating hypertension includes: delivering RF energy from a helically-configured electrode disposed on an inflated element within a renal artery into a renal nerve to disrupt renal nerve transmission to treat hypertension; and substantially continuously flowing fluid through the inflated element to cool tissue adjacent the helically-configured electrode.
  • a method of treating hypertension includes: positioning a unitary conductor comprising a helically-configured electrode disposed on an inflated element within a renal artery; delivering RF energy from the electrode and into a renal nerve to disrupt renal nerve transmission to treat hypertension; and flowing fluid through the inflated element to cool tissue adjacent the helically-configured electrode.
  • an RF delivery device adapted to treat hypertension includes an expandable element secured to an elongate device and a unitary conductor disposed on a portion of the elongate device and a portion of the inflatable element.
  • An insulation material is disposed on a portion of the unitary conductor, thereby forming a helically-configured electrode disposed on the expandable element.
  • the expandable element includes a plurality of apertures therein.
  • FIGS. 3A and 3B show a portion of an elongate device according to an embodiment of the present disclosure
  • FIG. 4 shows a portion of an energy delivery device comprising a temperature sensor according to an embodiment of the present disclosure
  • FIG. 6 illustrates an system for delivering energy to tissue according to an embodiment of the present disclosure
  • FIG. 7 illustrates a cross section of an energy delivery device with a helical electrode in use within a renal artery according to an embodiment of the present disclosure
  • FIG. 10 is a photograph showing tissue ablation in a general helical pattern caused by an energy delivery device with a helical electrode according to an embodiment of the present disclosure
  • FIGS. 11A-11H illustrate a method of manufacturing an energy delivery device with a helical electrode on an expandable element according to an embodiment of the present disclosure
  • FIG. 12 represents an embodiment of a system similar to that of FIG. 6 represented by the resistances of the various elements according to an embodiment of the present disclosure
  • FIG. 13 illustrates an alternative configuration in which a capacitor, inductor, or both may be incorporated in the circuit from FIG. 12 ;
  • FIG. 16 illustrates a portion of an energy delivery device including a helical electrode pair on an expandable element according to another embodiment of the present disclosure.
  • FIG. 1A illustrates a side view of a distal region of RF delivery device 10 .
  • Device 10 has proximal region 2 , intermediate region 4 , and distal region 6 .
  • Device 10 includes an elongate portion 12 and expandable portion 14 (shown in an expanded configuration) disposed on a distal region of elongate portion 12 .
  • Expandable portion 14 includes inflatable element 16 on which conductive material 18 is disposed.
  • FIG. 1B illustrates a perspective view of the portion of the device shown in FIG. 1A , with a rectangular section of inflatable element 16 removed to illustrate elongate portion 12 disposed inside inflatable element 16 .
  • Conductive material 18 is disposed on catheter 26 proximal to the expandable portion 14 , and it is also disposed on the cylindrical section of inflatable element 16 in a helical pattern forming a helical electrode 19 as shown.
  • insulation material 34 is disposed on the layer of conductive material 18 .
  • insulation material 34 is not disposed on the helical electrode, allowing energy to be delivered to tissue through conductive material 18 .
  • conductive material 18 is covered with a layer of insulation, and thus energy is not applied to tissue in those areas.
  • the conductive material that is not covered by dielectric material on the distal portion of the system is considered an electrode.
  • the conductive material and the electrode are in this embodiment the same material.
  • the conductive material 18 is disposed on substantially the entire catheter 26 in proximal region 2 of the device. “Substantially the entire,” or “substantially all,” or derivatives thereof as used herein include the entire surface of catheter 26 , but also includes most of the surface of the catheter. For example, if a few inches of the proximal end of catheter 26 are not covered with conductive material, conductive material is still considered to be disposed on substantially all of the catheter.
  • the conductive material 18 and insulation material 34 extend 360 degrees around the catheter shaft, as opposed to only covering discrete lateral sections of the catheter. Alternatively, in some embodiments the conductor covers only a portion of the lateral surface of the catheter shaft.
  • the conductive material and insulation material may cover the entirety or only a portion of the proximal transition section of the expandable portion.
  • the insulation will typically cover the entirety of the conductive material in this region.
  • the conductive material and insulation material could, however, also be disposed on the distal section 24 of expandable portion 14 .
  • the helical electrode makes about 0.5 revolutions to about 1.5 revolutions around the inflatable element. The number of revolutions is measured over the length of the helical electrode.
  • the electrode may extend from the proximal transition section to the distal transition section (as shown in FIG. 2 ), but the electrode may extend over any section of the inflatable element.
  • the proximal end of the electrode may be disposed distal to the proximal transition section, and the distal end of the electrode may be proximal to the distal transition section.
  • the electrode is considered to extend along a subset of the length of the central intermediate section of the expandable element.
  • the electrode makes about 1 revolution around the inflatable element. In some embodiments the electrode makes about 0.5 revolutions around the inflatable element. In some embodiments the electrode makes about 0.75 revolutions around the inflatable element. In some embodiments the electrode makes about 1 revolution around the inflatable element. In some embodiments the electrode makes about 1.25 revolutions around the inflatable element. In some embodiments the electrode makes about 1.5 revolutions around the inflatable element.
  • the device is adapted to be coupled to an RF generator, which supplies RF current through the conductive material 18 on catheter 26 and inflatable element 16 .
  • RE current can be delivered to the desired tissue.
  • Energy is thus applied to tissue in the configuration of the conductive material on the intermediate section 22 of the expandable portion 14 , which in this embodiment is a helical, or spiral, configuration.
  • catheter 26 is not covered with conductive material or insulation material.
  • Catheter 26 includes guide element lumen 36 and inflation lumen 28 , also referred to herein as irrigation lumen, extending therethrough.
  • Guide element lumen 36 extends from the proximal end of the device (not shown) to the distal end.
  • Irrigation lumen 28 extends from the proximal end of catheter 26 (not shown) to a location within inflatable element 16 .
  • Irrigation port 30 is located inside inflatable element 16 and is in between proximal and distal ends of irrigation lumen 28 .
  • Irrigation lumen 28 and irrigation port 30 provide for fluid communication between the irrigation lumen and the interior of inflatable element 16 .
  • catheter 26 ranges in size from 2 to 8 French, and in some embodiments is 4 Fr. In some embodiments the guide wire lumen is between 1 and 4 Fr and in some embodiments is 2.5 Fr.
  • Expandable portion 14 includes one or more irrigation apertures 38 to allow irrigation fluid to pass from inside inflatable element 16 to outside inflatable element 16 .
  • the irrigation apertures can be formed only in the electrode section of expandable portion 14 (see, for example, FIG. 1A ), only in the non-electrode section of inflatable portion 14 , or in both the electrode section and in the non-electrode section.
  • the irrigation fluid is adapted to cool the conductive material 18 and/or tissue.
  • the apertures allow for fluid to flow out of the balloon, allowing either a continuous or non-continuous supply of fluid from a fluid reservoir, through the lumen, and into the balloon.
  • the irrigation fluid is in some embodiments cooled prior to delivery.
  • FIG. 4 illustrates a portion of an embodiment of a RF delivery device.
  • Delivery device 110 is similar to the RF delivery device shown in FIGS. 1-3 .
  • Device 110 includes catheter shaft 126 covered with conductive material 118 , upon which insulation material 134 is disposed. Insulation material 134 is also disposed on the proximal transition section of the expandable portion 114 , similar to the embodiment shown in FIGS. 1-3 .
  • the inflatable element also has conductive material 118 disposed on the inflatable element in the form of a helical electrode.
  • Catheter 126 has guiding element lumen 136 and irrigation lumen 128 therein.
  • Device 110 also includes at least one marker 127 disposed on catheter 126 such that the marker is within expandable portion 114 (shown as a balloon).
  • Device 110 also includes irrigation port 130 in fluid communication with irrigation lumen 134 .
  • Device 110 also includes temperature sensor 129 , such as a thermocouple, a resistance temperature detector, or a thermistor, that is electrically coupled from the proximal end of the device (not shown) through irrigation lumen 128 , out of irrigation port 130 , and is secured at its distal region to catheter 126 .
  • the temperature sensor could alternatively be disposed on the inner or outer surface of inflatable element 116 .
  • marker 127 is a radio opaque marker comprised of Pt, PtIr, or other suitable radio opaque material.
  • the marker may also comprise features viewable under fluoroscopy that allow for the visualization of the rotational orientation of the marker, and therefore the expandable section. This allows the physician to note the location of and/or realign the expandable element and helical electrode as necessary within the renal artery.
  • the irrigation fluid is adapted to cool the electrode on the inflatable element.
  • the irrigation fluid cools the RF electrode as it flows within the inflatable element and after it passes through the apertures as it flows across the outer surface of the inflatable element.
  • Temperature sensor 129 is adapted to sense the temperature of the fluid within inflatable element 116 .
  • the signal from the temperature sensor may be used in a feedback control mechanism to control the flow of fluid from a fluid reservoir (now shown) into the inflatable element.
  • the irrigation fluid may be delivered at a substantially constant rate and the signal from the temperature sensor used as signal to automatically shut off the RF generator if the sensed fluid temperature is above a threshold limit, thereby terminating that portion of the procedure.
  • FIG. 5 illustrates a delivery device in which portions of the helical conductor have been covered by insulation material 734 , forming a plurality of discrete circularly-shaped windows surrounding apertures 717 on electrical conductor 718 . In this fashion a single conductor can be used to create a number of discrete burn zones following a helical path along and around a vessel wall.
  • FIG. 6 illustrates a system 300 adapted to deliver RF energy to treatment tissue.
  • System 300 includes RF energy delivery device 302 , which can comprise any of the RF energy delivery devices described herein. Delivery device 302 is shown including inflatable element 316 , helical energy delivery element 319 , irrigation apertures 330 , guidewire 310 , and elongate member 312 .
  • System 300 also includes external housing 320 , which includes display 322 and controller 324 . Housing includes connector 336 , which is adapted to connect to instrument interface cable 314 .
  • System 300 also includes fluid reservoir 326 , which is in fluid communication with delivery device 302 via irrigation line 328 .
  • the system also includes fluid pump 331 , optional pressure sensor 332 , and optional bubble sensor 334 .
  • System 300 also includes a grounding plate or set of grounding plates 340 interfaced to controller 324 via connector 346 .
  • Pressure sensor 332 includes a housing, which comprises capture portion 335 and a force sensor 333 .
  • Capture portion 335 is configured to substantially surround irrigation tube 328 . Additionally, capture portion 335 captures tubing 328 such that a portion of the wall of irrigation tube 328 is compressed against force sensor 333 .
  • the force experienced by the force sensor is then a function of the force associated by the compression of the irrigation tube and the pressure within the irrigation tube.
  • a measurement is made under a no flow condition that describes the offset associated with the compression of the irrigation tube. This offset measurement is made prior to the initiation of a procedure and may be repeated at the beginning of each power cycle. This value is then used as an offset for subsequent measurements made under flow conditions.
  • a force/pressure calibration per tubing type or per tube is then used to convert the force signal to a pressure value.
  • the disclosure includes methods of using any of the RF delivery devices and systems herein.
  • the devices and/or systems are used to treat hypertension by disrupting the transmission within renal nerves adjacent one or both renal arteries.
  • Thermal heating mechanisms control renal neuromodulation via thermal heating mechanisms. Many embodiments of such methods and systems may reduce renal sympathetic nerve activity. Thermally-induced neuromodulation may be achieved by heating structures associated with renal neural activity via an apparatus positioned proximate to target neural fibers. Thermally-induced neuromodulation can be achieved by applying thermal stress to neural structures through heating for influencing or altering these structures. Additionally or alternatively, the thermal neuromodulation can be due to, at least in part, alteration of vascular structures such as arteries, arterioles, capillaries, or veins that perfuse the target neural fibers or surrounding tissue.
  • vascular structures such as arteries, arterioles, capillaries, or veins that perfuse the target neural fibers or surrounding tissue.
  • Thermal heating mechanisms for neuromodulation include both thermal ablation and non-ablative thermal alteration or damage (e.g., via sustained heating or resistive heating).
  • Thermal heating mechanisms may include raising the temperature of target neural fibers above a desired threshold to achieve non-ablative thermal alteration, or above a higher temperature to achieve ablative thermal alteration.
  • the target temperature can be above body temperature (e.g., approximately 37 degrees C.) but less than about 45 degrees C. for non-ablative thermal alteration, or the target temperature can be about 45 degrees C. or higher for the ablative thermal alteration.
  • the length of exposure to thermal stimuli may be specified to affect an extent or degree of efficacy of the thermal neuromodulation.
  • the duration of exposure can be as short as about 5, about 10, about 15, about 20, about 25, or about 30 seconds, or could be longer, such as about 1 minute, or even longer, such as about 2 minutes.
  • the exposure can be intermittent or continuous to achieve the desired result.
  • thermally-induced renal neuromodulation may be achieved via generation and/or application of thermal energy to the target neural fibers, such as through application of a “thermal” energy field, including, electromagnetic energy, radiofrequency, ultrasound (including high-intensity focused ultrasound), microwave, light energy (including laser, infrared and near-infrared) etc., to the target neural fibers.
  • thermally-induced renal neuromodulation may be achieved via delivery of a pulsed or continuous thermal energy field to the target neural fibers.
  • the energy field can be sufficient magnitude and/or duration to thermally induce the neuromodulation in the target fibers (e.g., to heat or thermally ablate or necrose the fibers).
  • additional and/or alternative methods and systems can also be used for thermally-induced renal neuromodulation.
  • the energy field thermally modulates the activity along neural fibers that contribute to renal function via heating.
  • the thermal modulation at least partially denervates the kidney innervated by the neural fibers via heating. This may be achieved, for example, via thermal ablation or non-ablative alteration of the target neural fibers.
  • the RF delivery device is first positioned within one or more renal arteries and RF energy is delivered into renal nerves to disrupt the nerve transmission sufficiently to treat hypertension.
  • the disruption pattern within the artery preferably extends substantially 360 degrees around the artery. Electrodes that treat tissue falling diametrically in a single plane normal or oblique to the longitudinal axis of the vessel have been shown to increase the risk of stenosing a vessel treated with RF energy. Spiral, or helical, patterns as described herein create patterns of treated tissue for which the projection along the longitudinal axis is circular and therefore have a high probability of treating any renal nerve passing along the periphery of the renal artery.
  • Utilizing a single helical electrode as described herein provides procedural improvements over previous attempts.
  • the device need not be moved to disrupt tissue in a desired treatment configuration.
  • the device need not be moved axially or rotated to treat an entire renal nerve treatment region. This reduces the overall time of the treatment. Additionally, this allows energy to be delivered to a desired treatment region in a variety of patients with much greater predictability. Additionally, if markers are used that allow for rotational alignment, the device may be moved and/or removed and then replaced and realigned, allowing the procedure to be restarted at a later time.
  • FIG. 7 A method of using an RF delivery device to treat hypertension is shown in FIG. 7 , and will be described using the device in FIG. 4 and the system shown in FIG. 6 .
  • the methods described herein can be carried out by other systems and by other RF delivery devices, such as the RF devices described herein.
  • the RF delivery device is positioned in a renal artery using a percutaneous access through a femoral artery.
  • the expandable portion is delivered into the renal artery in a collapsed configuration (not shown).
  • fluid from fluid reservoir 326 is pumped in an open loop control configuration, under constant flow, through irrigation line 328 and into inflatable element 116 by pump 330 .
  • Fluid flow into inflatable element 116 causes inflatable element 116 to expand.
  • Device 110 in FIG. 7 is in a delivered, or expanded, configuration within renal artery 1000 .
  • the tunica intima 1001 is surrounded by the tunica media 1002 , which is in turn surrounded by adventitial tissue 1003 .
  • Tissue renal nerves 1004 are shown within the adventitial, and some renal nerves not shown will be found within the tunica media.
  • the fluid continually passes through apertures 138 in the expandable portion as it is replaced with new fluid from fluid reservoir 326 .
  • the conductive material 118 on the inflatable element fully assumes the helical configuration, as shown in FIGS. 4 and 7 .
  • RF energy is then delivered to the helical electrode on the inflatable element.
  • Control unit 324 controls the parameters of the RF alternating current being delivered through the conductive material on the catheter and the helical electrode on the inflatable element.
  • the RF signal characteristics are chosen to apply energy to depths at which the renal nerves are disposed to effectively ablate the renal nerves.
  • the power is selected to ablate a majority of the renal nerves adjacent to where the device is positioned within the renal nerve.
  • the tissue is ablated to a depth of between about 3 mm to about 7 mm from the tissue closest to the device in the renal artery.
  • the RF signal can have the following characteristics, but these are not intended to be limiting: the frequency is between about 400 KHz to about 500 KHz and is a sine wave; the power is between about 30 W to about 80 W, the voltage is between about 40 v and about 80 v; and the signal is an intermittent signal.
  • Tissue treated by the RF energy via the helical electrode comprised is shown as regions 1005 , delineated by a dashed line. As illustrated, a region of treated tissue 1005 adjacent to the cut away section of conductor 118 includes nerve 1004 .
  • the device is shown being used in monopolar mode with a return electrode 340 positioned somewhere on the patient's skin.
  • Control unit 324 controls the operation of pump 330 and therefore controls the flow rate of the fluid from reservoir into the inflatable element.
  • the pump is continuously pumping at constant flow rate such that the flow is continuous from the reservoir, as is illustrated in FIG. 7 .
  • the pump is operated in an open loop constant flow configuration where pump rate is not adjusted as a function of any control parameter other than an over-pressure condition sensed by pressure sensor 332 , in which case RF power delivery is terminated, the pump is turned off, and an over-pressure condition reported to the operator.
  • the pump is typically operated for a period of time which encompasses the delivery of the RF energy and turned off shortly after the conclusion of the procedure or if the pressure sensor senses an undesirable condition, discussed herein.
  • the irrigation fluid is delivered from the pump through irrigation line 328 to irrigation lumen 128 to irrigation port 130 into the inflatable element 116 , and then out of the inflatable element through irrigation apertures 138 .
  • the pressure measured at the pressure sensor is driven by flow rate and the series sum of the fluid resistance of all of the elements in the fluid path.
  • the choice of fluid flow rate is driven by the required cooling rate and limited by the amount of irrigant fluid that can be tolerated by the patient which is delivered during the sum of treatments cycles.
  • the system is designed such that at the desired fluid flow there is a defined operating pressure within the inflatable element.
  • An optimal inflatable element inflation pressure is a pressure that is sufficient to completely inflate the inflatable element such that the RF electrode engages the treatment tissue.
  • the operating pressure within the inflatable element will be driven by the fluid flow, the number of apertures, and their cross sections.
  • the distribution, number, and cross section of the irrigation apertures will be driven by the flow rate, the configuration of the electrode, the intended operating pressure, and the maximum desired exit velocity for the irrigation fluid. If the number of apertures is too small and the distribution too sparse some areas of the surface will not receive appropriate irrigation and thereby be subject to overheating and possible charring of tissue.
  • the mean exit velocity for the irrigation fluid will drop as the number of apertures is increased while decreasing the cross sectional area of each aperture such that the fluid resistance of the sum of apertures is appropriate to maintain the desired inflation pressure. Minimizing the irrigation fluid exit velocity minimizes or precludes the possibility that lesions will be eroded through the treatment tissue.
  • An inflation pressure between about 0.5 atm and less than about 4 atm used with a noncompliant inflatable element of approximately 0.75 mil ( ⁇ 19 um) thick ensures tissue engagement in a renal artery. In some particular embodiments the inflation pressure is about 2 atm+/ ⁇ 0.5 atm.
  • the irrigation fluid delivery rate is between about 1 mL/min and about 20 ml/min. In some particular embodiments the delivery rate is about 10 mL/min+/ ⁇ 2 mL/min.
  • the expandable portion includes eight irrigation apertures about 2.6 mil (0.0026 inches) in diameter distributed on either side of the helical electrode and equally spaced along the edge of the electrode. In such a configuration the mean exit velocity is about 6 msec. In some embodiments the maximum mean fluid exit velocity is between about 1 m/sec and about 20 msec.
  • the inflation pressure can be between about 0.5 atm (or less) and about 10 atm
  • the flow rate can be between about 1 mL/min to about 50 mL/min
  • any suitable number of apertures with any suitable size can be incorporated into the device.
  • Apertures may be of the same size or of different sizes and may also be uniformly or non-uniformly distributed through and/or about the electrode.
  • the apertures are sized such that the total resistance of the set of apertures is appropriate to maintain the pressures defined herein internal to the inflatable element at the desired flows described herein. Alternatively, the total resistance is such that the desired flows described herein are maintained at the desired pressures described herein.
  • the total resistance for the parallel combination of apertures is calculated as the inverse of the sum of the inverses of the individual aperture resistances.
  • the system shown also includes pressure sensor 332 , which is adapted to determine if the pressure rises above or below threshold limits. If the fluid pressure rises above an established limit, the controller shuts off the RF energy, and fluid pump 330 is automatically shut off. The pressure can elevate if one or more of the apertures become blocked, preventing fluid from passing out of the balloon, which can prevent the electrode from being cooled sufficiently. Controller 324 therefore runs fluid pump 330 in a binary manner, either open-flow or off.
  • the system as shown also includes a temperature sensor 129 secured to the catheter within the inflatable element. If the sensed temperature of the fluid is above a threshold limit, the fluid will not properly cool the electrode. If the sensed fluid temperature is above a threshold limit, control unit 324 is adapted to cease RF current delivery. The fluid temperature in the balloon can rise if one or more apertures are blocked, preventing the electrode from being properly cooled and also increasing the risk of charring. The fluid pressure generally will rise above a threshold limit if this occurs as well. In some embodiments the system has only one of the temperature sensor and pressure sensor.
  • the system may also include bubble sensor 334 , which is adapted to sense bubbles in the fluid line and communicates with control unit 324 to shut off pump 330 if bubbles of sufficient volume are detected.
  • bubble sensor 334 is adapted to sense bubbles in the fluid line and communicates with control unit 324 to shut off pump 330 if bubbles of sufficient volume are detected.
  • the system can also include a flow sensor to determine if the flow rate has gone below or above threshold limits. RF energy delivery is automatically stopped and the pump is automatically shut down if the flow rate goes above or below the threshold limits.
  • the constant flow control of the system may be replaced by constant pressure control.
  • the reservoir 326 may be maintained at a pressure within the prescribed pressure range using, for example without limitation, an IV bag pressure cuff or other suitable means, and the pump replaced by a flow sensor or flow controller.
  • pressure is maintained at a substantially constant level within the prescribed range and flow rate monitored. When flow rate falls outside of the proscribed range the RF power delivery is terminated.
  • FIG. 8 illustrates a portion of an embodiment of an RF delivery device wherein the expandable portion has a general dumbbell configuration, and energy is delivered through the conductive fluid to the tissue.
  • RF delivery device 210 includes expandable portion 222 that comprises inflatable element 216 on which is disposed conduction material 218 with a helical configuration.
  • the catheter has guiding element lumen 236 and irrigation lumen 228 .
  • a conductive layer and an insulation layer are disposed on the catheter as in the embodiment in FIGS. 1-5 .
  • the proximal and distal portions of inflatable element 216 have diameters that are greater than the intermediate section, such that the expandable portion has a general dumbbell shape.
  • Device 210 is also adapted to query the nervous tissues adjacent to the device, but need not include this functionality.
  • Device 210 includes nerve conduction electrodes 215 located on the outer surface of the dumbbell shaped proximal and distal ends of the expandable portion 214 .
  • an electrical signal typically a low current pulse or group of pulses is transmitted to one of the conduction electrodes. This triggers a response in adjacent renal nerves, which then travels along the nerves and at some time “t” later is sensed by the opposite electrode when the signal is traveling in the appropriate direction.
  • FIG. 9 illustrates the delivery device 210 in a delivered, or expanded, configuration within a renal artery.
  • Areas 1005 indicate tissue treated by the application of RF energy delivered via the helical electrode.
  • An area 1005 adjacent to conductor 218 surrounds a renal nerve 1004 .
  • Irrigation fluid movement is shown by the arrows.
  • the fluid enters the inflatable element 216 at irrigation port 230 as shown by arrows 1006 .
  • the fluid then flows out of inflatable element 216 at irrigation apertures 238 , shown by arrows 1007 .
  • the fluid then flows past conduction electrodes 215 into the blood stream, shown by arrows 1008 .
  • the dumbbell configuration creates a small space between the helical electrode and the arterial wall.
  • the irrigation fluid such as saline
  • the irrigation fluid can be used to act as a conductor and transfer energy from the electrode to the tissue.
  • the impedance variations, at the interface between the tissue and the electrode, associated with surface irregularities and variations in contact between the electrode and tissue will be minimized.
  • the fluid can act both to cool the electrode and to transfer energy to tissue.
  • the thin layer of fluid between the electrode and tissue can also prevent sticking and add lubrication.
  • FIG. 7 includes features associated with the embodiment from FIG. 4 .
  • RF delivery device 210 is less dependent on considerations listed above with respect to the embodiment in FIG. 4 as the irrigation fluid does not directly impinge on the treatment tissue and is allowed circulate in the space between the vessel wall and the cylindrical central section 222 . Such a configuration additionally requires less irrigation fluid to prevent charring as the electrode 129 does not contact the tissue directly.
  • the embodiment from FIG. 5 is used to create a discontinuous helical burn pattern formed of a plurality of discrete burn areas in the tissue.
  • the helical burn pattern is formed during a single treatment session and does not require the device be moved to create the plurality of discrete burn areas.
  • FIG. 10 is a photograph of an RF delivery device 410 on top of a piece of heart tissue 500 which has been ablated with RF energy delivered by a device similar to that in FIG. 4 and a system similar to that of FIG. 6 .
  • the heart tissue was originally cut as a cylinder into the core of which the distal end 406 of the RF delivery device 410 was deployed.
  • RF energy comprising a signal of 400K Hz at 40 volts and 40 watts was then delivered to the tissue.
  • the cylinder of tissue was then cut along its length so that the inner surface of the tissue cylinder could be visualized.
  • Helical burn zone 501 was created by helical electrode 419 .
  • the burn zone has the same configuration as the helical electrode.
  • FIGS. 11A-11H illustrate a method of manufacturing a portion of the RF delivery device 110 from FIG. 4 .
  • catheter 126 is provided and can be any suitable catheter or other elongate device, such as a sheath.
  • catheter 126 can be an extruded material, and optionally can have a stiffening element therein such as a braided material.
  • catheter 126 is extruded with a guide element lumen and an irrigation lumen formed therein (not shown), and the irrigation port is formed therein (not shown).
  • the irrigation lumen is closed off at the distal end of the catheter to prevent fluid from escaping the distal end of catheter, but the irrigation lumen can stop at the irrigation port rather than continuing further towards the distal end.
  • Inflatable element 116 which can be an inflatable balloon, is then secured to the exterior of catheter 126 using any suitable technique such that irrigation port 130 is disposed within inflatable element 116 .
  • mask 60 is applied or slid over inflatable element 116 .
  • the mask is configured such that it covers areas where the conductive material is not to be deposited and is open where conductive material is to be applied.
  • FIG. 11C mask 60 is configured with open area 61 to allow for the deposition of a conductive element 118 in a helical configuration.
  • Inflatable element 116 is then inflated with a suitable inflation fluid (e.g., liquid or gas) delivered through the irrigation lumen and out port 130 to expand, or inflate, inflatable element 116 , as shown in FIG. 11C .
  • a suitable inflation fluid e.g., liquid or gas
  • mask 60 is typically configured to mask the distal transition section of the expandable portion and the catheter distal to the expandable portion.
  • conductive material 118 is then deposited, in a single deposition step, onto substantially all of catheter 126 , portions of inflatable element 116 , and mask 60 . This forms a conductive material layer on substantially all of catheter 26 , proximal portion of inflatable element 116 , and in the helical pattern on inflatable element 116 .
  • the conduction material 118 is deposited in the single step and allowed to dry sufficiently and or cure, inflatable element 116 is deflated and the mask 60 is removed. As shown in FIG.
  • a second mask 70 is then applied over those areas of conductive material 118 which are intended to deliver energy directly to the tissue in the energy delivery pattern, which is the helical pattern.
  • the inflatable element 216 is then re-inflated and insulation material 34 is applied to substantially the entire device in a single depositing step as shown in FIG. 11G . This forms an insulation layer on substantially the entire conductive material already deposited on catheter 126 , the proximal portion of the inflatable element, and the intermediate portion of the inflatable element where mask 70 is not disposed.
  • the inflatable element is deflated and the mask 70 removed as shown in FIG. 11H .
  • shaft 126 , and proximal transition section of inflatable element is encapsulated by conductor 118 which are in turn encapsulated by dielectric 134 , while helical conductive electrode 118 on the inflatable element is not covered with dielectric.
  • the irrigation apertures are then formed, such as by laser drilling.
  • the layers of conductive material and insulation material are between about 0.0001 and about 0.001 inches thick. In some embodiments the conductive layer is about 0.0003 inches thick. In some embodiments the insulation layer is about 0.0005 inches thick.
  • Alternate methods for deposition of the conductor and/or the dielectric layers which that can be used and do not require masking include ink jet and or pad printing techniques.
  • a “unitary conductor” as described herein is a single conductive material comprising both a conduction element and an electrode element wherein the conductive element communicates energy between the controller and the electrode element.
  • the conductive and insulation materials can each be deposited on substantially all of elongate portion 112 (excluding the portion within expandable portion 114 ) and expandable portion 114 in a single step, reducing the time necessary to form the conductive and insulation layers, respectively. This can also simplify the manufacturing process.
  • the device can be secured to a mandrel and spun while the material is deposited, or the device can be secured in place while the device used to deposit the material is moved relative to the device, or a combination of the two steps.
  • Single step as used herein includes a step that applies the material without stopping the deposition of material.
  • the conductive material can be deposited on substantially all of the catheter proximal to the inflatable element and to the inflatable element in a single step.
  • “Single step” as used herein also includes applying a second or more coats to the elongate portion and the expandable portion after initially ceasing the deposition of material. For example, a process that applies a first coat of conductive material to substantially all of the catheter proximal to the inflatable element and to the inflatable element, followed by a ceasing of the deposition, but followed by application of a second coat to substantially the entire portion of the catheter proximal to the inflatable element and to the inflatable element, would be considered a “single step” as used herein.
  • electrical junction refers to a connection created between two conductive materials, either the same or different materials, that allows an electrical signal to be conducted from one material to the other.
  • the inflatable element is, in some embodiments, an inflatable balloon that is adapted to be inflated upon the delivery of a fluid through the irrigation lumen and out of the irrigation port.
  • the inflatable element is a balloon made of non-elastic, or non-compliant, material, but it can be a compliant, or elastic, material as well.
  • Materials for a non-compliant balloon include, without limitation, polyethylene, polyethylene terephthalate, polypropylene, cross-linked polyethylene, polyurethane, and polyimide.
  • Materials for a compliant balloon include, without limitation, nylon, silicon, latex, and polyurethane.
  • the length of the cylindrical intermediate portion of the inflatable element is between about 1 cm and about 4 cm. In some embodiments the inflatable element has a diameter between about 4 mm and about 10 mm. In some particular embodiments the length of the intermediate portion of the inflatable element is about 20 mm and the diameter is about 5 mm to about 7 mm.
  • the conductive material can be deposited onto the catheter and/or expandable portion.
  • Methods of depositing include, without limitation, pad printing, screen printing, spraying, ink jet, vapor deposition, ion beam assisted deposition, electroplating, electroless plating, or other printed circuit manufacturing processes.
  • the conductive material deposited is an elastomeric ink and the dielectric material is an elastomeric ink. They can be sprayed on the respective components.
  • the elastomeric ink is diluted with an appropriate diluent to an appropriate viscosity then sprayed in a number of coats while the delivery device is rotated beneath a linearly translating spray head.
  • Conductive materials that can be deposited on the device to form one or more conductive layers of the device include conductive inks (e.g., electrically conductive silver ink, electrically conductive carbon ink, an electrical conductive gold ink), conductive powders, conductive pastes, conductive epoxies, conductive adhesives, conductive polymers or polymeric materials such as elastomers, or other conductive materials.
  • conductive inks e.g., electrically conductive silver ink, electrically conductive carbon ink, an electrical conductive gold ink
  • conductive powders e.g., electrically conductive silver ink, electrically conductive carbon ink, an electrical conductive gold ink
  • conductive powders e.g., conductive pastes, conductive epoxies, conductive adhesives, conductive polymers or polymeric materials such as elastomers, or other conductive materials.
  • the conductive material comprises an elastomeric matrix filled with conductive particles.
  • Elastomeric components include silicones and polyurethanes.
  • Conductive materials are conductive metals such as gold or silver.
  • Conductive inks that can be used are conductive ink CI-1065 and CI-1036 manufactured by ECM of Delaware Ohio. This ink is an extremely abrasion resistant, flexible, and highly conductive elastomeric ink. The ink has the following properties: 65% solids in the form of silver flakes; 0.015 ohms/square (1 mil (0.001 inches) thick); and a 10 minute cure time at 248 F.
  • the electrodes described herein can also be used as a temperature sensor.
  • Ablative electrodes are routinely used in wide variety of surgical procedures. Many of these procedures are performed percutaneously, and a subset are performed endovascularly. In many of these procedures it is customary to incorporate provisions to monitor the temperature of the ablative electrodes. This temperature information is then used in some fashion as an input in a control scheme to limit the maximum temperature the electrode is allowed to attain. In this fashion a number of mechanisms, that may be deleterious to the desired outcome, may be controlled and or limited. Some of these effects, which in some circumstances are considered deleterious are, tissue charring, creation of steam, and the resultant uncontrolled, rapid, or large changes in interface impedance.
  • the temperature monitoring is typically carried out by incorporating and mounting some form of a temperature sensor such as a thermocouple, an rdt, or a thermistor in proximity to, or on, the electrode.
  • a temperature sensor such as a thermocouple, an rdt, or a thermistor in proximity to, or on, the electrode.
  • the electrodes are typically comprised of metals or metal alloys which are either deposited as metals directly through various metal deposition procedures such as, but not limited to physical or chemical metal vapor deposition, or applied as a component in a matrix such as but not limited to organic polymers in the form of an ink.
  • metals or metal alloys which are either deposited as metals directly through various metal deposition procedures such as, but not limited to physical or chemical metal vapor deposition, or applied as a component in a matrix such as but not limited to organic polymers in the form of an ink.
  • Such inks are deposited in many ways, a few of which are, screening, spraying, ink jetting.
  • thermo coefficient of resistance typically a temperature coefficient of resistance or “tempco.”
  • the magnitude and characteristics of these effects varies and is often used in devices such as a resistance temperature detector “RTD”, such as a platinum rtd's, or in positive temperature coefficient “PTC” or negative temperature coefficient “NTC” thermistors.
  • RTD resistance temperature detector
  • PTC positive temperature coefficient
  • NTC negative temperature coefficient
  • the systems herein can therefore alternatively monitor temperature by using the inherent tempco of the electrode itself as a way of monitoring its temperature and or controlling its impedance and thereby self-limiting its power output and thereby its temperature.
  • FIG. 12 represents an embodiment of a system similar to that of FIG. 6 represented by the resistances of the various elements.
  • the delivery RF lead which runs down catheter is represented as resistance 626 and the electrode is represented by resistance 619 .
  • the leads whose resistances are represented by 626 and 650 may be sourced in parallel when RF is delivered to electrode 619 and addressed separately when used to characterize the resistance and hence temperature of the electrode 619 . Alternatively one of them may be used solely for the purpose of monitoring temperature and therefore left open circuited when RF is being delivered.
  • the design of the delivery system and electrode will be such that the impedance 640 of the patient will be orders of magnitude greater then the impedances for the delivery leads 626 , 650 , and the electrode 619 .
  • impedance 619 will be considerably greater than 626 or 650 , or in some cases the parallel combination of 626 and 650 .
  • the electrode is comprised of a layer of platinum and the temperature of the electrode may be characterized by monitoring the voltage drop across the series resistances 626 , 619 , 650 . This may be done intermittently, interspersed in the delivery of the RF energy. As the electrode heats, its resistance will increase in a well-known and repeatable fashion. As the leads 626 and 650 have lower resistance and will not self-heat appreciable, the change in resistance will by primarily due to the heating of electrode 619 and variation in its resistance. Many other scenarios will be understood to those skilled in the art.
  • An alternate arrangement which relies on the use of a PTC for the electrode relies on the rapid change in resistance of the electrode past a particular set point which is a function of the composition of the electrode.
  • the tempco of the electrode is relatively small, for example, below about 40 C but above about 40 C. In this temperature range the tempco rapidly increases thereby limiting delivered power in a voltage-limited RF configuration.
  • FIG. 13 illustrates an alternative configuration in which a capacitor 648 , inductor (not shown), or both may be incorporated in the circuit.
  • the circuit may incorporate only one source lead 621 and the inherent resonance of the circuit which will depend on the varying impedance of the electrode resistance 623 .
  • the tempco associated with a conductive ink such as the ECM CI-1036 may be used.
  • ECM CI-1036 demonstrated a 0.1% increase in impedance per degree over the range of 30 C to 60 C.
  • the device disclosed in FIG. 16 is another embodiment of a device adapted for such purpose.
  • the device described herein comprises a bipolar electrode pair disposed on the outer surface of an expandable structure comprised of an inflatable balloon.
  • a bipolar electrode pair provides for both a more controlled burn and a shallower burn than a comparable monopolar electrode.
  • the device is configured for endovascular delivery to a renal artery.
  • Each of the individual electrodes comprising the bipolar set is in turn comprised of a unitary electrode/conductor.
  • the distal portion of an bipolar RF delivery device 810 includes an expandable section 850 including a balloon, and a catheter shaft section 820 including an inner shaft 830 and an outer shaft 840 .
  • the inner lumen of the inner shaft 830 includes a guidewire lumen 822 .
  • the annular gap between the inner and outer shafts includes an irrigation lumen 821 .
  • the outer shaft 840 also includes an irrigation outflow 812 (e.g., an irrigation port) located near its distal end such that it is disposed within the balloon.
  • a temperature sensor 811 may be located within the balloon 850 and interconnecting leads of the temperature sensor 811 may be routed through the irrigation lumen outflow 812 and irrigation lumen 821 .
  • a conductive material is deposited on substantially the entire inner shaft 830 .
  • a dielectric material is then deposited on the conductive material except at the distal most end of the inner shaft 830 .
  • the inner shaft 830 is then fitted within the outer shaft 840 and the two are affixed to one another such that the inner shaft 830 extends beyond the most distal portion of the outer shaft 840 and the balloon 850 .
  • the dielectric on the inner shaft 830 is deposited on at least the portions of the surface of the conductor on the inner shaft 830 that would contact irrigation fluid, thus preventing the conductive material on the inner shaft 830 from coming into contact with irrigation fluid.
  • the distal end of the inner shaft 830 which extends distal to the outer shaft 840 , is not coated with dielectric. This allows the inner shaft 830 to be in electrical communication with the inner sourced electrode as described below.
  • the outer shaft 840 and balloon 850 are coated with an elastomeric ink, and then, subsequently, by a dielectric as described above.
  • the conductive coating is deposited on the outer shaft 840 , all or a portion of the proximal cone 843 of the balloon 850 , and on the balloon 850 , forming a conductive material that includes an outer sourced spiral electrode 842 .
  • This conductive material can be deposited in a unitary manner, as is described above and in the materials incorporated by reference herein.
  • Conductive material is also deposited on the most distal section of the shaft assembly, the distal cone portion 833 of the balloon 850 , and the balloon 850 , forming a conductive material that includes an inner sourced electrode 832 .
  • This conductor can also be formed in a unitary manner.
  • the conductive material that forms the inner sourced electrode can be the same material that is used for the outer sourced electrode.
  • the distal conductor (which includes the inner sourced electrode 832 ) is formed, it interfaces electrically with the conductor on the inner shaft 830 that extends distal to the balloon 850 .
  • the conductive materials can be selected such that when the conductive materials are deposited, the interface is a single layer of the same material rather than two distinct layers.
  • the conductor and dielectric structures can be fabricated as described above. When used in bipolar mode, energy passes from one spiral electrode 832 or 842 , through renal nerve tissue, to the other electrode.
  • the electrodes 832 , 842 can be used in a bipolar manner, or each electrode can be used in monopolar mode. Bipolar mode can be used if the tissue burn need not be as deep as may be needed if using a monopolar mode. Bipolar mode generally allows more control in the tissue burn. Additionally or alternatively, the electrodes 832 , 842 can be used together as a single monopolar electrode (e.g., by feeding both electrodes with the same frequency and RF energy such that the electrodes appear to be one electrode).
  • the inner shaft is not coated with a conductor (or dielectric) and, instead, a wire extends through the irrigation lumen, and interfaces the conductor that includes the inner sourced electrode.
  • irrigation ports as described above can be situated such that they pass through the electrode structures, sit adjacent to the electrode structures such as in the space between them or exterior to the pair, or both.
  • One or more radio opaque markers 813 may be affixed to the outer shaft.

Abstract

The present disclosure is directed to an expandable energy delivery assembly adapted to deliver electrical energy to tissue. The assembly includes an elongate device and an expandable portion. The expandable portion includes an inflatable element, a single helical electrode disposed on the inflatable element, and at least one irrigation aperture within the inflatable element. The inflatable element is secured to the elongate device and the single helical electrode makes between about 0.5 and about 1.5 revolutions around the inflatable element. The at least one irrigation aperture is adapted to allow fluid to flow from within the inflatable element to outside the inflatable element.

Description

    CROSS REFERENCE TO RELATED APPLICATIONS
  • The present application claims the benefit of priority to U.S. Provisional Application Ser. No. 61/541,765, filed on Sep. 30, 2011, and to U.S. Provisional Application Ser. No. 61/593,147, filed on Jan. 31, 2012, with the entire contents of each of these applications incorporated herein by reference. This application is also related to and incorporates by reference herein the complete disclosures of the following patent applications: U.S. Provisional Pat. App. No. 61/113,228, filed Dec. 11, 2008; U.S. Provisional Pat. App. No. 61/160,204, filed Mar. 13, 2009; U.S. Provisional Pat. App. No. 61/179,654, filed May 19, 2009; U.S. Pat. App. Pub. No. 2010/0204560, filed Nov. 11, 2009; U.S. Provisional Pat. App. No. 61/334,154, filed May 12, 2010; and U.S. patent application Ser. No. 13/106,658, filed May 12, 2011.
  • INCORPORATION BY REFERENCE
  • All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.
  • TECHNICAL FIELD
  • The present disclosure relates generally to medical devices and methods and more particularly to devices and methods for applying radiofrequency energy to tissue.
  • BACKGROUND
  • Some medical treatment procedures involve the disruption of a region of tissue. For example, medical treatment procedures include the delivery of energy to disrupt a region of tissue. Radiofrequency (“RF”) energy devices are an example of devices that can be used to perform such medical treatments.
  • Some RF energy devices have a single RF energy element or a plurality of discrete RF energy elements that have to be repeatedly moved within the subject in order to apply sufficient RF energy to the entire region of the tissue. Such RF energy devices may need to be moved within a patient during a given procedure, which can increase the complexity, time, and energy required to perform a given procedure.
  • SUMMARY
  • This description may use the phrases “in an embodiment,” “in embodiments,” “in some embodiments,” or “in other embodiments,” which may each refer to one or more of the same or different embodiments in accordance with the present disclosure. For the purposes of this description, a phrase in the form “A/B” means A or B. For the purposes of the description, a phrase in the form “A and/or B” means “(A), (B), or (A and B)”. For the purposes of this description, a phrase in the form “at least one of A, B, or C” means “(A), (B), (C), (A and B), (A and C), (B and C), or (A, B and C)”.
  • As used herein, the terms proximal and distal refer to a direction or a position along a longitudinal axis of a catheter or medical instrument. The term “proximal” refers to the end of the catheter or medical instrument closer to the operator, while the term “distal” refers to the end of the catheter or medical instrument closer to the patient. For example, a first point is proximal to a second point if it is closer to the operator end of the catheter or medical instrument than the second point. The measurement term “French”, abbreviated Fr or F, is defined as three times the diameter of a device as measured in mm. Thus, a 3 mm diameter catheter is 9 French in diameter. The term “operator” refers to any medical professional (i.e., doctor, surgeon, nurse, or the like) performing a medical procedure involving the use of aspects of the present disclosure described herein.
  • In an aspect of the present disclosure, an expandable energy delivery assembly adapted to deliver electrical energy to tissue is provided. The assembly includes an elongate device and an expandable portion. The expandable portion includes an inflatable element, a single helical electrode disposed on the inflatable element, and at least one irrigation aperture within the inflatable element. The inflatable element is secured to the elongate device and the single helical electrode makes between about 0.5 and about 1.5 revolutions around the inflatable element. The at least one irrigation aperture is adapted to allow fluid to flow from within the inflatable element to outside the inflatable element.
  • The single helical electrode may make between about 1 and about 1.25 revolutions around the inflatable element.
  • A conductive material may be disposed on the elongate device proximal to the expandable portion to electrically couple the single helical electrode to an electrical energy source, wherein the conductive material is disposed on substantially the entire elongate device proximal to the expandable portion. An insulation material may be disposed on substantially all of the conductive material on the elongate device.
  • The conductive material and the single helical electrode may form a unitary conductive material without an electrical junction. The conductive material and the helical electrode may be an elastomeric ink.
  • The expandable portion may include a proximal transition section covered with a conductive material that electrically couples the helical electrode and the conductive material on the elongate device. An insulation material may be disposed on the conductive material on the transition shaped section.
  • The inflatable element is a balloon with a substantially cylindrical section, where the single helical electrode is disposed on the substantially cylindrical section. Additionally or alternatively, the at least one irrigation aperture is in the inflatable element, in the helical electrode, and/or adjacent the helical electrode.
  • In certain embodiments, the elongate device includes an irrigation lumen therein and an irrigation port therein. The irrigation port can be disposed within the inflatable element and can provide fluid communication between the irrigation lumen and the interior of the inflatable element.
  • In another aspect of the present disclosure, an expandable energy delivery assembly adapted to deliver energy to tissue is provided. The assembly includes an elongate device and an expandable element secured thereto. The assembly also includes a unitary conductive material disposed on substantially all of the elongate device proximal to the expandable element and on a portion of the expandable element. The unitary conductor being void of an electrical junction.
  • The expandable element may be an inflatable balloon. In some embodiments, the conductive material on the expandable element forms a single helix. The expandable element can include a transition portion with the conductive material also being disposed on the transition portion. An insulation material may be disposed over substantially all of the conductive material on the elongate device proximal to the expandable element. The transition portion may include a conically-shaped portion.
  • In yet another aspect of the present disclosure, an expandable energy delivery assembly adapted to deliver energy to tissue is provided that includes an elongate device comprising an irrigation lumen therethrough and an irrigation port proximal to a distal end of the elongate device. An inflatable element is secured to the elongate device such that the irrigation port is disposed within a fluid chamber defined by the inflatable element. An electrode is disposed on the inflatable element and at least one irrigation aperture is provided and adapted to allow fluid to pass from within the fluid chamber to outside the inflatable element. The irrigation aperture is sized to maintain a pressure within the inflatable element between about 0.5 atm and about 4 atm when a substantially constant irrigation flow rate is between about 5 mL/min and about 15 mL/min.
  • The assembly may also include a temperature sensor adapted to measure fluid temperature and may further include an energy source and a controller, the controller being adapted to automatically turn off the energy source if a sensed fluid temperature is above a threshold limit. The temperature sensor can be disposed within the inflatable element.
  • In some embodiments, the assembly includes a flow rate sensor adapted to sense fluid flow rate and may further include an energy source and a controller, the controller being adapted to automatically turn off the energy source if a sensed flow rate falls below a minimum value.
  • The assembly may include a pressure sensor adapted to sense fluid pressure and may further include an energy source and a controller, the controller being adapted to automatically turn off the energy source if a sensed pressure falls below a minimum value.
  • In yet another aspect of the present disclosure, a method of manufacturing an expandable energy delivery assembly adapted to deliver energy to tissue is provided. The method includes: providing an inflatable element secured to an elongate device; inflating the inflatable element; and depositing a conductive material on an exterior surface of the inflatable element to form a single helical electrode making between about 0.5 and about 1.5 revolutions around the inflatable element.
  • Depositing may include vapor deposition, electroplating, electroless plating, pad printing, spraying, or ink jet. A mask may be applied to the inflatable element before the depositing step. In some embodiments, the depositing step includes depositing the conductive material on substantially all of the elongate device proximal to the inflatable device and on the inflatable element, forming a unitary conductor. The depositing step may also include depositing the conductive material on a conical section of the inflatable element.
  • In some embodiments, the mask is removed, a second mask is applied over the helical electrode, and an insulation material is deposited over substantially all of the elongate device proximal to the inflatable element. Depositing the insulation material can include depositing the insulation material over a transition section of the inflatable element. Additionally or alternatively, applying the second mask can include applying the second mask over an entire intermediate section of the inflatable element.
  • In yet another aspect of the present disclosure, a method of manufacturing an expandable energy delivery assembly adapted to deliver energy to tissue is provided that includes: providing an inflatable element secured to an elongate device; inflating the inflatable element; and depositing a conductive material on the elongate device and a portion of the inflatable element in a single depositing step to form a unitary conductor without an electrical junction.
  • The depositing step may include depositing the conductive material on substantially the entire elongate device proximal to the inflatable element. Additionally or alternatively, depositing may include depositing the conductive material in a helical pattern on the inflatable element.
  • A mask may be applied over the inflatable element. In certain embodiments, the depositing step also includes depositing the conductive material over a transition section of the inflatable element.
  • An insulation layer is deposited over the conductive material on the elongate device.
  • The depositing step may include depositing an elastomeric conductive material on the elongate device and a portion of the inflatable element in a single depositing step to form an elastomeric unitary conductor.
  • In some embodiments, depositing the conductive material includes depositing the conductive material using vapor deposition, electroplating, electroless plating, pad printing and spraying, or ink jet.
  • In yet another aspect of the present disclosure, a method of providing an irrigation fluid to an inflatable medical device includes: providing an elongate device with an inflatable element secured thereto, the inflatable element defining a fluid chamber and comprising at least one irrigation aperture therein to allow a fluid to flow through the inflatable element, the elongate device comprising an irrigation lumen extending therethrough that provides fluid communication to the inflatable chamber; continuously flowing the fluid at a substantially constant flow rate between about 5 mL/min and about 15 mL/min from a fluid source and into the irrigation lumen while allowing fluid to flow out of the fluid chamber through the at least one irrigation aperture; and maintaining a fluid pressure within the inflatable element between about 0.5 atm and about 4 atm.
  • In yet another aspect of the present disclosure, a method of providing an irrigation fluid to an inflatable medical device includes: providing an elongate device with an inflatable element secured thereto, the inflatable element defining a fluid chamber and comprising at least one irrigation aperture therein to allow a fluid to flow through the inflatable element, the elongate device comprising an irrigation lumen extending therethrough that provides fluid communication to the inflatable chamber; and maintaining a substantially constant pressure between about 0.5 atm and about 4 atm within the inflatable element sufficient to maintain a flow rate of between about 5 mL/min and about 15 mL/min through the inflatable element and out of at least one irrigation aperture
  • In some embodiments, these methods include delivering RF energy to tissue via an energy element disposed on the inflatable element. Additionally or alternatively, a temperature of the fluid may be sensed such that, for example, the delivery of RF energy can be stopped if the sensed temperature is above a threshold temperature. The delivery of RF energy may be stopped if the pressure within the inflatable element falls outside of a control range and/or if the flow through the inflatable element falls outside of a control range. The RF energy may be delivered through a unitary conductor comprising an electrode that may be, for example, a helically-configured electrode.
  • In certain embodiments, these methods include endovascularly disposing the inflatable element in a renal artery, applying RF energy through an electrode on the inflatable element to renal nerves to disrupt transmission of neural signals along the renal nerves to treat hypertension.
  • In yet another aspect of the present disclosure, a method of delivering RF energy to tissue includes: providing an elongate device with an inflatable element secured thereto, the inflatable element defining a fluid chamber and comprising at least one irrigation aperture therein to allow the fluid to flow through the inflatable element, the elongate device comprising an irrigation lumen extending therethrough that provides fluid communication to the inflatable chamber from a fluid source; continuously flowing a fluid at a substantially constant flow rate from the fluid source; sensing a temperature of the fluid; automatically stopping the delivery of RF energy to an electrode on the inflatable element if the sensed fluid temperature is above a threshold temperature.
  • Sensing a temperature of the fluid may include sensing a temperature of the fluid within the fluid chamber. Delivery of RF energy to an electrode on the inflatable element can be automatically stopped if the sensed fluid temperature is above about 60 degrees C.
  • In some embodiments, the method further includes endovascularly positioning the inflatable element within a renal artery, and RF energy is applied through the electrode on the inflatable element to renal nerves to disrupt transmission of neural signals along the renal nerves to treat hypertension. The RF energy may be delivered through a unitary conductor including an electrode that may be, for example, a helically-configured electrode.
  • In yet another aspect of the present disclosure, a method of treating hypertension is provided that includes: delivering RF energy from a helically-configured electrode disposed on an inflated element within a renal artery into a renal nerve to disrupt renal nerve transmission to treat hypertension; and substantially continuously flowing fluid through the inflated element to cool tissue adjacent the helically-configured electrode.
  • In yet another aspect of the present disclosure, a method of treating hypertension is provided that includes: positioning a unitary conductor comprising a helically-configured electrode disposed on an inflated element within a renal artery; delivering RF energy from the electrode and into a renal nerve to disrupt renal nerve transmission to treat hypertension; and flowing fluid through the inflated element to cool tissue adjacent the helically-configured electrode.
  • In yet another aspect of the present disclosure, an RF delivery device adapted to treat hypertension includes an expandable element secured to an elongate device and a unitary conductor disposed on a portion of the elongate device and a portion of the inflatable element. An insulation material is disposed on a portion of the unitary conductor, thereby forming a helically-configured electrode disposed on the expandable element. The expandable element includes a plurality of apertures therein.
  • In yet another aspect of the present disclosure, an expandable energy delivery assembly adapted to deliver electrical energy to tissue includes an elongate device and an expandable portion. The expandable portion includes an inflatable element, a first helical electrode disposed on the inflatable element, a second helical electrode disposed on the inflatable element and at least one irrigation aperture within the inflatable element. The inflatable element is secured to the elongate device, the first helical electrode makes between about 0.5 and about 1.5 revolutions around the inflatable element, the second helical electrode makes between about 0.5 and about 1.5 revolutions around the inflatable element, and the at least one irrigation aperture allows fluid to flow from within the inflatable element to outside the inflatable element.
  • In certain embodiments, the first helical electrode and the second helical electrode may be configured to operate in a bipolar mode or the first helical electrode or the second helical electrode may be configured to operate in a monopolar mode.
  • BRIEF DESCRIPTION OF THE DRAWINGS
  • FIGS. 1A, 1B, and 2 illustrate a portion of an energy delivery device comprising a helical electrode on an expandable element according to an embodiment of the present disclosure;
  • FIGS. 3A and 3B show a portion of an elongate device according to an embodiment of the present disclosure;
  • FIG. 4 shows a portion of an energy delivery device comprising a temperature sensor according to an embodiment of the present disclosure;
  • FIG. 5 illustrates a portion of an energy delivery device wherein portions of a helical electrode are covered with an insulation material according to an embodiment of the present disclosure;
  • FIG. 6 illustrates an system for delivering energy to tissue according to an embodiment of the present disclosure;
  • FIG. 7 illustrates a cross section of an energy delivery device with a helical electrode in use within a renal artery according to an embodiment of the present disclosure;
  • FIGS. 8 and 9 illustrate a portion of an energy delivery device wherein energy is delivered to renal nerves through conductive fluid to the tissue according to an embodiment of the present disclosure;
  • FIG. 10 is a photograph showing tissue ablation in a general helical pattern caused by an energy delivery device with a helical electrode according to an embodiment of the present disclosure;
  • FIGS. 11A-11H illustrate a method of manufacturing an energy delivery device with a helical electrode on an expandable element according to an embodiment of the present disclosure;
  • FIG. 12 represents an embodiment of a system similar to that of FIG. 6 represented by the resistances of the various elements according to an embodiment of the present disclosure;
  • FIG. 13 illustrates an alternative configuration in which a capacitor, inductor, or both may be incorporated in the circuit from FIG. 12;
  • FIGS. 14 and 15 illustrate an embodiment of a pressure sensor according to an embodiment of the present disclosure; and
  • FIG. 16 illustrates a portion of an energy delivery device including a helical electrode pair on an expandable element according to another embodiment of the present disclosure.
  • DETAILED DESCRIPTION
  • Particular embodiments of the present disclosure are described hereinbelow with reference to the accompanying drawings; however, the disclosed embodiments are merely examples of the disclosure and may be embodied in various forms. Like reference numerals may refer to similar or identical elements throughout the description of the figures.
  • One aspect of the disclosure is a RF delivery device that is adapted to deliver RF energy to tissue. FIG. 1A illustrates a side view of a distal region of RF delivery device 10. Device 10 has proximal region 2, intermediate region 4, and distal region 6. Device 10 includes an elongate portion 12 and expandable portion 14 (shown in an expanded configuration) disposed on a distal region of elongate portion 12. Expandable portion 14 includes inflatable element 16 on which conductive material 18 is disposed.
  • FIG. 1B illustrates a perspective view of the portion of the device shown in FIG. 1A, with a rectangular section of inflatable element 16 removed to illustrate elongate portion 12 disposed inside inflatable element 16.
  • FIG. 2 shows a sectional view of the portion of the device shown in FIG. 1A. Expandable portion 14 includes a proximal transition section 20, intermediate section 22, and distal transition section 24. Proximal transition section 20 and distal transition section 24 are shown with conical configurations extending towards elongate portion 12 but are not limited to this configuration. Intermediate section 22 is substantially cylindrically-shaped when inflatable element 16 is in the expanded configuration shown in FIGS. 1A, 1B, and 2. The proximal end of inflatable element 16 and the distal end of inflatable element 16 are secured to catheter 26, which is part of elongate portion 12.
  • Conductive material 18 is disposed on catheter 26 proximal to the expandable portion 14, and it is also disposed on the cylindrical section of inflatable element 16 in a helical pattern forming a helical electrode 19 as shown. In proximal region 2 and in proximal section 20 of the expandable portion, insulation material 34 is disposed on the layer of conductive material 18. In the cylindrical intermediate section 22 of expandable portion 14, insulation material 34 is not disposed on the helical electrode, allowing energy to be delivered to tissue through conductive material 18. In the proximal region 2 of the device, and in proximal section 20 of expandable portion 14, conductive material 18 is covered with a layer of insulation, and thus energy is not applied to tissue in those areas. The conductive material that is not covered by dielectric material on the distal portion of the system is considered an electrode. The conductive material and the electrode are in this embodiment the same material.
  • The conductive material 18 is disposed on substantially the entire catheter 26 in proximal region 2 of the device. “Substantially the entire,” or “substantially all,” or derivatives thereof as used herein include the entire surface of catheter 26, but also includes most of the surface of the catheter. For example, if a few inches of the proximal end of catheter 26 are not covered with conductive material, conductive material is still considered to be disposed on substantially all of the catheter. The conductive material 18 and insulation material 34 extend 360 degrees around the catheter shaft, as opposed to only covering discrete lateral sections of the catheter. Alternatively, in some embodiments the conductor covers only a portion of the lateral surface of the catheter shaft. The conductive material and insulation material may cover the entirety or only a portion of the proximal transition section of the expandable portion. The insulation will typically cover the entirety of the conductive material in this region. The conductive material and insulation material could, however, also be disposed on the distal section 24 of expandable portion 14.
  • In some embodiments the helical electrode makes about 0.5 revolutions to about 1.5 revolutions around the inflatable element. The number of revolutions is measured over the length of the helical electrode. The electrode may extend from the proximal transition section to the distal transition section (as shown in FIG. 2), but the electrode may extend over any section of the inflatable element. For example, the proximal end of the electrode may be disposed distal to the proximal transition section, and the distal end of the electrode may be proximal to the distal transition section.
  • One revolution traverses 360 degrees around the longitudinal axis of the expandable element. One revolution of the electrode, along an end-view of inflatable device, forms a circle, although depending on the cross sectional shape of the expandable element, the electrode can form any variety of shapes in an end-view. An electrode making 0.5 revolutions therefore traverses one half of 360 degrees, or 180 degrees. An electrode making 0.5 revolutions has distal and proximal ends that are on opposite sides of the balloon. In an end-view of the inflatable element with a circular cross section, an electrode making 0.5 revolutions has a semi-circular, or C, shape.
  • The proximal end of the electrode can be disposed anywhere on the expandable element and the distal end of the electrode can be anywhere on the expandable element, as long as the proximal end is proximal to the distal end. In some embodiments, the proximal end of the electrode is at the boundary between the proximal transition section and the cylindrical intermediate section of the expandable element, and the distal end of the electrode is at the boundary between the distal transition section and the cylindrical intermediate section. In other embodiments the proximal end of the electrode is disposed distal to the boundary between the proximal intermediate section and the cylindrical intermediate section of the expandable element, and the distal end is proximal to the boundary between the distal transition section and the central intermediate section of the expandable element. In these other embodiments the electrode is considered to extend along a subset of the length of the central intermediate section of the expandable element. In the embodiment shown in FIG. 1B, the electrode makes about 1 revolution around the inflatable element. In some embodiments the electrode makes about 0.5 revolutions around the inflatable element. In some embodiments the electrode makes about 0.75 revolutions around the inflatable element. In some embodiments the electrode makes about 1 revolution around the inflatable element. In some embodiments the electrode makes about 1.25 revolutions around the inflatable element. In some embodiments the electrode makes about 1.5 revolutions around the inflatable element.
  • The device is adapted to be coupled to an RF generator, which supplies RF current through the conductive material 18 on catheter 26 and inflatable element 16. In this manner RE current can be delivered to the desired tissue. Energy is thus applied to tissue in the configuration of the conductive material on the intermediate section 22 of the expandable portion 14, which in this embodiment is a helical, or spiral, configuration.
  • Within the expandable portion, catheter 26 is not covered with conductive material or insulation material. Catheter 26 includes guide element lumen 36 and inflation lumen 28, also referred to herein as irrigation lumen, extending therethrough. Guide element lumen 36 extends from the proximal end of the device (not shown) to the distal end. Irrigation lumen 28 extends from the proximal end of catheter 26 (not shown) to a location within inflatable element 16. Irrigation port 30 is located inside inflatable element 16 and is in between proximal and distal ends of irrigation lumen 28. Irrigation lumen 28 and irrigation port 30 provide for fluid communication between the irrigation lumen and the interior of inflatable element 16. FIGS. 3A and 3B illustrate additional views of guide element lumen 36, irrigation lumen 28, and irrigation port 30. In some embodiments catheter 26 ranges in size from 2 to 8 French, and in some embodiments is 4 Fr. In some embodiments the guide wire lumen is between 1 and 4 Fr and in some embodiments is 2.5 Fr.
  • Expandable portion 14 includes one or more irrigation apertures 38 to allow irrigation fluid to pass from inside inflatable element 16 to outside inflatable element 16. The irrigation apertures can be formed only in the electrode section of expandable portion 14 (see, for example, FIG. 1A), only in the non-electrode section of inflatable portion 14, or in both the electrode section and in the non-electrode section. The irrigation fluid is adapted to cool the conductive material 18 and/or tissue. The apertures allow for fluid to flow out of the balloon, allowing either a continuous or non-continuous supply of fluid from a fluid reservoir, through the lumen, and into the balloon. The irrigation fluid is in some embodiments cooled prior to delivery.
  • FIG. 4 illustrates a portion of an embodiment of a RF delivery device. Delivery device 110 is similar to the RF delivery device shown in FIGS. 1-3. Device 110 includes catheter shaft 126 covered with conductive material 118, upon which insulation material 134 is disposed. Insulation material 134 is also disposed on the proximal transition section of the expandable portion 114, similar to the embodiment shown in FIGS. 1-3. The inflatable element also has conductive material 118 disposed on the inflatable element in the form of a helical electrode. Catheter 126 has guiding element lumen 136 and irrigation lumen 128 therein. Device 110 also includes at least one marker 127 disposed on catheter 126 such that the marker is within expandable portion 114 (shown as a balloon). Device 110 also includes irrigation port 130 in fluid communication with irrigation lumen 134. Device 110 also includes temperature sensor 129, such as a thermocouple, a resistance temperature detector, or a thermistor, that is electrically coupled from the proximal end of the device (not shown) through irrigation lumen 128, out of irrigation port 130, and is secured at its distal region to catheter 126. The temperature sensor could alternatively be disposed on the inner or outer surface of inflatable element 116. In some embodiments marker 127 is a radio opaque marker comprised of Pt, PtIr, or other suitable radio opaque material. In some embodiments the marker may also comprise features viewable under fluoroscopy that allow for the visualization of the rotational orientation of the marker, and therefore the expandable section. This allows the physician to note the location of and/or realign the expandable element and helical electrode as necessary within the renal artery.
  • The irrigation fluid is adapted to cool the electrode on the inflatable element. The irrigation fluid cools the RF electrode as it flows within the inflatable element and after it passes through the apertures as it flows across the outer surface of the inflatable element. Temperature sensor 129 is adapted to sense the temperature of the fluid within inflatable element 116. The signal from the temperature sensor may be used in a feedback control mechanism to control the flow of fluid from a fluid reservoir (now shown) into the inflatable element. Alternatively, the irrigation fluid may be delivered at a substantially constant rate and the signal from the temperature sensor used as signal to automatically shut off the RF generator if the sensed fluid temperature is above a threshold limit, thereby terminating that portion of the procedure. Such a condition is considered a fault and after identification and resolution of a fault, a procedure may be restarted. FIG. 5 illustrates a delivery device in which portions of the helical conductor have been covered by insulation material 734, forming a plurality of discrete circularly-shaped windows surrounding apertures 717 on electrical conductor 718. In this fashion a single conductor can be used to create a number of discrete burn zones following a helical path along and around a vessel wall.
  • One aspect of the disclosure is a system to delivery RF energy to treatment tissue. FIG. 6 illustrates a system 300 adapted to deliver RF energy to treatment tissue. System 300 includes RF energy delivery device 302, which can comprise any of the RF energy delivery devices described herein. Delivery device 302 is shown including inflatable element 316, helical energy delivery element 319, irrigation apertures 330, guidewire 310, and elongate member 312. System 300 also includes external housing 320, which includes display 322 and controller 324. Housing includes connector 336, which is adapted to connect to instrument interface cable 314. System 300 also includes fluid reservoir 326, which is in fluid communication with delivery device 302 via irrigation line 328. The system also includes fluid pump 331, optional pressure sensor 332, and optional bubble sensor 334. System 300 also includes a grounding plate or set of grounding plates 340 interfaced to controller 324 via connector 346.
  • An embodiment of pressure sensor 332 from the system in FIG. 6 is shown in FIGS. 14 and 15. Pressure sensor 332 includes a housing, which comprises capture portion 335 and a force sensor 333. Capture portion 335 is configured to substantially surround irrigation tube 328. Additionally, capture portion 335 captures tubing 328 such that a portion of the wall of irrigation tube 328 is compressed against force sensor 333. The force experienced by the force sensor is then a function of the force associated by the compression of the irrigation tube and the pressure within the irrigation tube. In operation, a measurement is made under a no flow condition that describes the offset associated with the compression of the irrigation tube. This offset measurement is made prior to the initiation of a procedure and may be repeated at the beginning of each power cycle. This value is then used as an offset for subsequent measurements made under flow conditions. A force/pressure calibration per tubing type or per tube is then used to convert the force signal to a pressure value.
  • The disclosure includes methods of using any of the RF delivery devices and systems herein. In some embodiments the devices and/or systems are used to treat hypertension by disrupting the transmission within renal nerves adjacent one or both renal arteries.
  • The present methods control renal neuromodulation via thermal heating mechanisms. Many embodiments of such methods and systems may reduce renal sympathetic nerve activity. Thermally-induced neuromodulation may be achieved by heating structures associated with renal neural activity via an apparatus positioned proximate to target neural fibers. Thermally-induced neuromodulation can be achieved by applying thermal stress to neural structures through heating for influencing or altering these structures. Additionally or alternatively, the thermal neuromodulation can be due to, at least in part, alteration of vascular structures such as arteries, arterioles, capillaries, or veins that perfuse the target neural fibers or surrounding tissue.
  • Thermal heating mechanisms for neuromodulation include both thermal ablation and non-ablative thermal alteration or damage (e.g., via sustained heating or resistive heating). Thermal heating mechanisms may include raising the temperature of target neural fibers above a desired threshold to achieve non-ablative thermal alteration, or above a higher temperature to achieve ablative thermal alteration. For example, the target temperature can be above body temperature (e.g., approximately 37 degrees C.) but less than about 45 degrees C. for non-ablative thermal alteration, or the target temperature can be about 45 degrees C. or higher for the ablative thermal alteration.
  • The length of exposure to thermal stimuli may be specified to affect an extent or degree of efficacy of the thermal neuromodulation. For example, the duration of exposure can be as short as about 5, about 10, about 15, about 20, about 25, or about 30 seconds, or could be longer, such as about 1 minute, or even longer, such as about 2 minutes. In other embodiments, the exposure can be intermittent or continuous to achieve the desired result.
  • In some embodiments, thermally-induced renal neuromodulation may be achieved via generation and/or application of thermal energy to the target neural fibers, such as through application of a “thermal” energy field, including, electromagnetic energy, radiofrequency, ultrasound (including high-intensity focused ultrasound), microwave, light energy (including laser, infrared and near-infrared) etc., to the target neural fibers. For example, thermally-induced renal neuromodulation may be achieved via delivery of a pulsed or continuous thermal energy field to the target neural fibers. The energy field can be sufficient magnitude and/or duration to thermally induce the neuromodulation in the target fibers (e.g., to heat or thermally ablate or necrose the fibers). As described herein, additional and/or alternative methods and systems can also be used for thermally-induced renal neuromodulation.
  • The energy field thermally modulates the activity along neural fibers that contribute to renal function via heating. In several embodiments, the thermal modulation at least partially denervates the kidney innervated by the neural fibers via heating. This may be achieved, for example, via thermal ablation or non-ablative alteration of the target neural fibers.
  • In some uses in which RF energy is used to ablate the renal nerve, the RF delivery device is first positioned within one or more renal arteries and RF energy is delivered into renal nerves to disrupt the nerve transmission sufficiently to treat hypertension. The disruption pattern within the artery preferably extends substantially 360 degrees around the artery. Electrodes that treat tissue falling diametrically in a single plane normal or oblique to the longitudinal axis of the vessel have been shown to increase the risk of stenosing a vessel treated with RF energy. Spiral, or helical, patterns as described herein create patterns of treated tissue for which the projection along the longitudinal axis is circular and therefore have a high probability of treating any renal nerve passing along the periphery of the renal artery. The patterns, however, have minimal risk of creating a stenosis. Previous attempts have used a point electrode at a distal end or distal region of a device. In these attempts, the electrode is disposed in the renal artery followed by RF energy delivery. To disrupt renal nerve tissue in a non circumferential pattern using a point electrode, the device is first positioned within the renal artery adjacent arterial tissue. RF energy is then delivered to disrupt a region of renal nerve. The device must then be moved axially (distally or proximally) and rotated, followed by additional RF delivery. The movement and RF delivery is repeated in a pattern until the renal nerves have been sufficiently disrupted. The repeated movements are time consuming and increase the complexity of the overall process for the physician. During an emergency situation the physician may lose track of the position and sequence of previous burns thereby jeopardizing the likelihood of creating a pattern sufficient to treat the neural tissue or be forced to increase the number of burns thereby over-treating the patient.
  • Utilizing a single helical electrode as described herein provides procedural improvements over previous attempts. By using an electrode with the configuration of the desired treatment region, the device need not be moved to disrupt tissue in a desired treatment configuration. In particular the device need not be moved axially or rotated to treat an entire renal nerve treatment region. This reduces the overall time of the treatment. Additionally, this allows energy to be delivered to a desired treatment region in a variety of patients with much greater predictability. Additionally, if markers are used that allow for rotational alignment, the device may be moved and/or removed and then replaced and realigned, allowing the procedure to be restarted at a later time.
  • A method of using an RF delivery device to treat hypertension is shown in FIG. 7, and will be described using the device in FIG. 4 and the system shown in FIG. 6. The methods described herein can be carried out by other systems and by other RF delivery devices, such as the RF devices described herein.
  • The RF delivery device is positioned in a renal artery using a percutaneous access through a femoral artery. The expandable portion is delivered into the renal artery in a collapsed configuration (not shown). Once the expandable portion is in position, fluid from fluid reservoir 326 is pumped in an open loop control configuration, under constant flow, through irrigation line 328 and into inflatable element 116 by pump 330. Fluid flow into inflatable element 116 causes inflatable element 116 to expand. Device 110 in FIG. 7 is in a delivered, or expanded, configuration within renal artery 1000. The tunica intima 1001 is surrounded by the tunica media 1002, which is in turn surrounded by adventitial tissue 1003. Tissue renal nerves 1004 are shown within the adventitial, and some renal nerves not shown will be found within the tunica media.
  • The fluid continually passes through apertures 138 in the expandable portion as it is replaced with new fluid from fluid reservoir 326. Once fully expanded, the conductive material 118 on the inflatable element fully assumes the helical configuration, as shown in FIGS. 4 and 7. RF energy is then delivered to the helical electrode on the inflatable element. Control unit 324 controls the parameters of the RF alternating current being delivered through the conductive material on the catheter and the helical electrode on the inflatable element.
  • In general, the RF signal characteristics are chosen to apply energy to depths at which the renal nerves are disposed to effectively ablate the renal nerves. In general, the power is selected to ablate a majority of the renal nerves adjacent to where the device is positioned within the renal nerve. In some embodiments the tissue is ablated to a depth of between about 3 mm to about 7 mm from the tissue closest to the device in the renal artery.
  • The RF signal can have the following characteristics, but these are not intended to be limiting: the frequency is between about 400 KHz to about 500 KHz and is a sine wave; the power is between about 30 W to about 80 W, the voltage is between about 40 v and about 80 v; and the signal is an intermittent signal.
  • Tissue treated by the RF energy via the helical electrode comprised is shown as regions 1005, delineated by a dashed line. As illustrated, a region of treated tissue 1005 adjacent to the cut away section of conductor 118 includes nerve 1004. The device is shown being used in monopolar mode with a return electrode 340 positioned somewhere on the patient's skin.
  • Control unit 324 controls the operation of pump 330 and therefore controls the flow rate of the fluid from reservoir into the inflatable element. In some embodiments the pump is continuously pumping at constant flow rate such that the flow is continuous from the reservoir, as is illustrated in FIG. 7. In some embodiments the pump is operated in an open loop constant flow configuration where pump rate is not adjusted as a function of any control parameter other than an over-pressure condition sensed by pressure sensor 332, in which case RF power delivery is terminated, the pump is turned off, and an over-pressure condition reported to the operator. The pump is typically operated for a period of time which encompasses the delivery of the RF energy and turned off shortly after the conclusion of the procedure or if the pressure sensor senses an undesirable condition, discussed herein.
  • The irrigation fluid is delivered from the pump through irrigation line 328 to irrigation lumen 128 to irrigation port 130 into the inflatable element 116, and then out of the inflatable element through irrigation apertures 138. The pressure measured at the pressure sensor is driven by flow rate and the series sum of the fluid resistance of all of the elements in the fluid path. The choice of fluid flow rate is driven by the required cooling rate and limited by the amount of irrigant fluid that can be tolerated by the patient which is delivered during the sum of treatments cycles. The system is designed such that at the desired fluid flow there is a defined operating pressure within the inflatable element. An optimal inflatable element inflation pressure is a pressure that is sufficient to completely inflate the inflatable element such that the RF electrode engages the treatment tissue. The operating pressure within the inflatable element will be driven by the fluid flow, the number of apertures, and their cross sections. The distribution, number, and cross section of the irrigation apertures will be driven by the flow rate, the configuration of the electrode, the intended operating pressure, and the maximum desired exit velocity for the irrigation fluid. If the number of apertures is too small and the distribution too sparse some areas of the surface will not receive appropriate irrigation and thereby be subject to overheating and possible charring of tissue. For a set of circular apertures and a given flow rate, the mean exit velocity for the irrigation fluid will drop as the number of apertures is increased while decreasing the cross sectional area of each aperture such that the fluid resistance of the sum of apertures is appropriate to maintain the desired inflation pressure. Minimizing the irrigation fluid exit velocity minimizes or precludes the possibility that lesions will be eroded through the treatment tissue.
  • A set of operating conditions and design parameters is now provided, and is not meant to be limiting. An inflation pressure between about 0.5 atm and less than about 4 atm used with a noncompliant inflatable element of approximately 0.75 mil (˜19 um) thick ensures tissue engagement in a renal artery. In some particular embodiments the inflation pressure is about 2 atm+/−0.5 atm. The irrigation fluid delivery rate is between about 1 mL/min and about 20 ml/min. In some particular embodiments the delivery rate is about 10 mL/min+/−2 mL/min. The expandable portion includes eight irrigation apertures about 2.6 mil (0.0026 inches) in diameter distributed on either side of the helical electrode and equally spaced along the edge of the electrode. In such a configuration the mean exit velocity is about 6 msec. In some embodiments the maximum mean fluid exit velocity is between about 1 m/sec and about 20 msec.
  • The above operating parameters are not intended to be limiting. For example, the inflation pressure can be between about 0.5 atm (or less) and about 10 atm, the flow rate can be between about 1 mL/min to about 50 mL/min, and any suitable number of apertures with any suitable size can be incorporated into the device. Apertures may be of the same size or of different sizes and may also be uniformly or non-uniformly distributed through and/or about the electrode. The apertures are sized such that the total resistance of the set of apertures is appropriate to maintain the pressures defined herein internal to the inflatable element at the desired flows described herein. Alternatively, the total resistance is such that the desired flows described herein are maintained at the desired pressures described herein. The total resistance for the parallel combination of apertures is calculated as the inverse of the sum of the inverses of the individual aperture resistances.
  • The system shown also includes pressure sensor 332, which is adapted to determine if the pressure rises above or below threshold limits. If the fluid pressure rises above an established limit, the controller shuts off the RF energy, and fluid pump 330 is automatically shut off. The pressure can elevate if one or more of the apertures become blocked, preventing fluid from passing out of the balloon, which can prevent the electrode from being cooled sufficiently. Controller 324 therefore runs fluid pump 330 in a binary manner, either open-flow or off.
  • The system as shown also includes a temperature sensor 129 secured to the catheter within the inflatable element. If the sensed temperature of the fluid is above a threshold limit, the fluid will not properly cool the electrode. If the sensed fluid temperature is above a threshold limit, control unit 324 is adapted to cease RF current delivery. The fluid temperature in the balloon can rise if one or more apertures are blocked, preventing the electrode from being properly cooled and also increasing the risk of charring. The fluid pressure generally will rise above a threshold limit if this occurs as well. In some embodiments the system has only one of the temperature sensor and pressure sensor.
  • The system may also include bubble sensor 334, which is adapted to sense bubbles in the fluid line and communicates with control unit 324 to shut off pump 330 if bubbles of sufficient volume are detected.
  • The system can also include a flow sensor to determine if the flow rate has gone below or above threshold limits. RF energy delivery is automatically stopped and the pump is automatically shut down if the flow rate goes above or below the threshold limits.
  • In an alternate embodiment to that of FIG. 6 the constant flow control of the system may be replaced by constant pressure control. In such a system the reservoir 326 may be maintained at a pressure within the prescribed pressure range using, for example without limitation, an IV bag pressure cuff or other suitable means, and the pump replaced by a flow sensor or flow controller. In such a system pressure is maintained at a substantially constant level within the prescribed range and flow rate monitored. When flow rate falls outside of the proscribed range the RF power delivery is terminated.
  • In general, using a greater number of smaller holes provides substantially the same resistance as a fewer number of larger holes, but mean fluid exit velocity is diminished.
  • FIG. 8 illustrates a portion of an embodiment of an RF delivery device wherein the expandable portion has a general dumbbell configuration, and energy is delivered through the conductive fluid to the tissue. RF delivery device 210 includes expandable portion 222 that comprises inflatable element 216 on which is disposed conduction material 218 with a helical configuration. The catheter has guiding element lumen 236 and irrigation lumen 228. A conductive layer and an insulation layer are disposed on the catheter as in the embodiment in FIGS. 1-5. The proximal and distal portions of inflatable element 216 have diameters that are greater than the intermediate section, such that the expandable portion has a general dumbbell shape. When inflated, larger diameter proximal and distal ends of the expandable portion 214 contact the vessel wall, while space is left between the cylindrical section 222 of the expandable element and the vessel wall as illustrated in FIG. 8. The irrigation fluid flowing through irrigation apertures 238 fills the space between the cylindrical section 222 and tissue, and current from the helical electrode is carried through the conductive irrigation fluid and into the adjacent tissue. In this configuration the helical electrode does not contact tissue directly, therefore the uniformity of heating is improved and the risk of charring or overheating the tissue is reduced.
  • Device 210 is also adapted to query the nervous tissues adjacent to the device, but need not include this functionality. Device 210 includes nerve conduction electrodes 215 located on the outer surface of the dumbbell shaped proximal and distal ends of the expandable portion 214. In use, an electrical signal, typically a low current pulse or group of pulses is transmitted to one of the conduction electrodes. This triggers a response in adjacent renal nerves, which then travels along the nerves and at some time “t” later is sensed by the opposite electrode when the signal is traveling in the appropriate direction. By alternating which electrode is used as the exciter and which the sensor, both changes in efferent and afferent nerve conduction in the renal nerves may be monitored as a function of RF treatments induced by the RF electrode. The conduction electrodes are wired to the sensing circuits in the controller via wires traveling within the catheter shaft, as in the irrigation lumen, or additional lumens (not shown), or multiple conductors may be applied to the outer surface of the shaft (not shown).
  • FIG. 9 illustrates the delivery device 210 in a delivered, or expanded, configuration within a renal artery. Areas 1005 indicate tissue treated by the application of RF energy delivered via the helical electrode. An area 1005 adjacent to conductor 218 surrounds a renal nerve 1004. Irrigation fluid movement is shown by the arrows. The fluid enters the inflatable element 216 at irrigation port 230 as shown by arrows 1006. The fluid then flows out of inflatable element 216 at irrigation apertures 238, shown by arrows 1007. The fluid then flows past conduction electrodes 215 into the blood stream, shown by arrows 1008.
  • In use, the dumbbell configuration creates a small space between the helical electrode and the arterial wall. The irrigation fluid, such as saline, can be used to act as a conductor and transfer energy from the electrode to the tissue. In such a system, the impedance variations, at the interface between the tissue and the electrode, associated with surface irregularities and variations in contact between the electrode and tissue will be minimized. In this manner the fluid can act both to cool the electrode and to transfer energy to tissue. The thin layer of fluid between the electrode and tissue can also prevent sticking and add lubrication.
  • Unless specifically stated to the contrary, the embodiment of FIG. 7 includes features associated with the embodiment from FIG. 4.
  • The configuration of RF delivery device 210 is less dependent on considerations listed above with respect to the embodiment in FIG. 4 as the irrigation fluid does not directly impinge on the treatment tissue and is allowed circulate in the space between the vessel wall and the cylindrical central section 222. Such a configuration additionally requires less irrigation fluid to prevent charring as the electrode 129 does not contact the tissue directly.
  • In use, the embodiment from FIG. 5 is used to create a discontinuous helical burn pattern formed of a plurality of discrete burn areas in the tissue. The helical burn pattern is formed during a single treatment session and does not require the device be moved to create the plurality of discrete burn areas.
  • FIG. 10 is a photograph of an RF delivery device 410 on top of a piece of heart tissue 500 which has been ablated with RF energy delivered by a device similar to that in FIG. 4 and a system similar to that of FIG. 6. The heart tissue was originally cut as a cylinder into the core of which the distal end 406 of the RF delivery device 410 was deployed. RF energy comprising a signal of 400K Hz at 40 volts and 40 watts was then delivered to the tissue. The cylinder of tissue was then cut along its length so that the inner surface of the tissue cylinder could be visualized. Helical burn zone 501 was created by helical electrode 419. The burn zone has the same configuration as the helical electrode.
  • One aspect of the disclosure is a method of manufacturing RF delivery devices. FIGS. 11A-11H illustrate a method of manufacturing a portion of the RF delivery device 110 from FIG. 4. In FIG. 11A, catheter 126 is provided and can be any suitable catheter or other elongate device, such as a sheath. For example, catheter 126 can be an extruded material, and optionally can have a stiffening element therein such as a braided material. In this embodiment catheter 126 is extruded with a guide element lumen and an irrigation lumen formed therein (not shown), and the irrigation port is formed therein (not shown). The irrigation lumen is closed off at the distal end of the catheter to prevent fluid from escaping the distal end of catheter, but the irrigation lumen can stop at the irrigation port rather than continuing further towards the distal end.
  • Inflatable element 116, which can be an inflatable balloon, is then secured to the exterior of catheter 126 using any suitable technique such that irrigation port 130 is disposed within inflatable element 116. Next, mask 60 is applied or slid over inflatable element 116. The mask is configured such that it covers areas where the conductive material is not to be deposited and is open where conductive material is to be applied. In FIG. 11C, mask 60 is configured with open area 61 to allow for the deposition of a conductive element 118 in a helical configuration. Inflatable element 116 is then inflated with a suitable inflation fluid (e.g., liquid or gas) delivered through the irrigation lumen and out port 130 to expand, or inflate, inflatable element 116, as shown in FIG. 11C. Additionally, mask 60 is typically configured to mask the distal transition section of the expandable portion and the catheter distal to the expandable portion. After mask 60 is applied, conductive material 118 is then deposited, in a single deposition step, onto substantially all of catheter 126, portions of inflatable element 116, and mask 60. This forms a conductive material layer on substantially all of catheter 26, proximal portion of inflatable element 116, and in the helical pattern on inflatable element 116. After the conduction material 118 is deposited in the single step and allowed to dry sufficiently and or cure, inflatable element 116 is deflated and the mask 60 is removed. As shown in FIG. 11F, a second mask 70 is then applied over those areas of conductive material 118 which are intended to deliver energy directly to the tissue in the energy delivery pattern, which is the helical pattern. The inflatable element 216 is then re-inflated and insulation material 34 is applied to substantially the entire device in a single depositing step as shown in FIG. 11G. This forms an insulation layer on substantially the entire conductive material already deposited on catheter 126, the proximal portion of the inflatable element, and the intermediate portion of the inflatable element where mask 70 is not disposed. Next, after appropriate drying and or curing the inflatable element is deflated and the mask 70 removed as shown in FIG. 11H. After mask 70 is removed, shaft 126, and proximal transition section of inflatable element is encapsulated by conductor 118 which are in turn encapsulated by dielectric 134, while helical conductive electrode 118 on the inflatable element is not covered with dielectric. The irrigation apertures are then formed, such as by laser drilling.
  • In some embodiments of manufacturing the device, the layers of conductive material and insulation material are between about 0.0001 and about 0.001 inches thick. In some embodiments the conductive layer is about 0.0003 inches thick. In some embodiments the insulation layer is about 0.0005 inches thick.
  • Alternate methods for deposition of the conductor and/or the dielectric layers which that can be used and do not require masking include ink jet and or pad printing techniques.
  • These methods of manufacturing form a unitary conductor. A “unitary conductor” as described herein is a single conductive material comprising both a conduction element and an electrode element wherein the conductive element communicates energy between the controller and the electrode element.
  • The conductive and insulation materials can each be deposited on substantially all of elongate portion 112 (excluding the portion within expandable portion 114) and expandable portion 114 in a single step, reducing the time necessary to form the conductive and insulation layers, respectively. This can also simplify the manufacturing process. To deposit the conductive and insulation material, the device can be secured to a mandrel and spun while the material is deposited, or the device can be secured in place while the device used to deposit the material is moved relative to the device, or a combination of the two steps. “Single step” as used herein includes a step that applies the material without stopping the deposition of material. For example, the conductive material can be deposited on substantially all of the catheter proximal to the inflatable element and to the inflatable element in a single step. “Single step” as used herein also includes applying a second or more coats to the elongate portion and the expandable portion after initially ceasing the deposition of material. For example, a process that applies a first coat of conductive material to substantially all of the catheter proximal to the inflatable element and to the inflatable element, followed by a ceasing of the deposition, but followed by application of a second coat to substantially the entire portion of the catheter proximal to the inflatable element and to the inflatable element, would be considered a “single step” as used herein. Some previous attempts to form a conductive material on an elongate device formed one or more discrete conductive elements on the elongate device, thus complicating the deposition process. These and other attempts failed to appreciate being able to form a single layer of conductive material on substantially all of the catheter or other elongate device. These attempts failed to appreciate being able to form single layer of conductive material on the catheter and an electrode element on an expandable element in a single step.
  • By disposing the conductive material on the external surfaces of the catheter and inflatable element in a single step, the creation of electrical junctions is avoided. For example, a junction need not be formed between the conductive material on the catheter and the conductive material on the inflatable element. As used herein, electrical junction refers to a connection created between two conductive materials, either the same or different materials, that allows an electrical signal to be conducted from one material to the other.
  • The inflatable element is, in some embodiments, an inflatable balloon that is adapted to be inflated upon the delivery of a fluid through the irrigation lumen and out of the irrigation port. In the embodiment in FIGS. 1-11, the inflatable element is a balloon made of non-elastic, or non-compliant, material, but it can be a compliant, or elastic, material as well. Materials for a non-compliant balloon include, without limitation, polyethylene, polyethylene terephthalate, polypropylene, cross-linked polyethylene, polyurethane, and polyimide. Materials for a compliant balloon include, without limitation, nylon, silicon, latex, and polyurethane.
  • In some embodiments of the embodiment in FIG. 4, the length of the cylindrical intermediate portion of the inflatable element is between about 1 cm and about 4 cm. In some embodiments the inflatable element has a diameter between about 4 mm and about 10 mm. In some particular embodiments the length of the intermediate portion of the inflatable element is about 20 mm and the diameter is about 5 mm to about 7 mm.
  • The conductive material can be deposited onto the catheter and/or expandable portion. Methods of depositing include, without limitation, pad printing, screen printing, spraying, ink jet, vapor deposition, ion beam assisted deposition, electroplating, electroless plating, or other printed circuit manufacturing processes.
  • In some embodiments the conductive material deposited is an elastomeric ink and the dielectric material is an elastomeric ink. They can be sprayed on the respective components. In some embodiments the elastomeric ink is diluted with an appropriate diluent to an appropriate viscosity then sprayed in a number of coats while the delivery device is rotated beneath a linearly translating spray head.
  • Conductive materials that can be deposited on the device to form one or more conductive layers of the device include conductive inks (e.g., electrically conductive silver ink, electrically conductive carbon ink, an electrical conductive gold ink), conductive powders, conductive pastes, conductive epoxies, conductive adhesives, conductive polymers or polymeric materials such as elastomers, or other conductive materials.
  • In some embodiments the conductive material comprises an elastomeric matrix filled with conductive particles. Elastomeric components include silicones and polyurethanes. Conductive materials are conductive metals such as gold or silver. Conductive inks that can be used are conductive ink CI-1065 and CI-1036 manufactured by ECM of Delaware Ohio. This ink is an extremely abrasion resistant, flexible, and highly conductive elastomeric ink. The ink has the following properties: 65% solids in the form of silver flakes; 0.015 ohms/square (1 mil (0.001 inches) thick); and a 10 minute cure time at 248 F.
  • The electrodes described herein can also be used as a temperature sensor. Ablative electrodes are routinely used in wide variety of surgical procedures. Many of these procedures are performed percutaneously, and a subset are performed endovascularly. In many of these procedures it is customary to incorporate provisions to monitor the temperature of the ablative electrodes. This temperature information is then used in some fashion as an input in a control scheme to limit the maximum temperature the electrode is allowed to attain. In this fashion a number of mechanisms, that may be deleterious to the desired outcome, may be controlled and or limited. Some of these effects, which in some circumstances are considered deleterious are, tissue charring, creation of steam, and the resultant uncontrolled, rapid, or large changes in interface impedance.
  • The temperature monitoring is typically carried out by incorporating and mounting some form of a temperature sensor such as a thermocouple, an rdt, or a thermistor in proximity to, or on, the electrode.
  • The electrodes are typically comprised of metals or metal alloys which are either deposited as metals directly through various metal deposition procedures such as, but not limited to physical or chemical metal vapor deposition, or applied as a component in a matrix such as but not limited to organic polymers in the form of an ink. Such inks are deposited in many ways, a few of which are, screening, spraying, ink jetting.
  • Metals, metal alloys, and other metal compound have resistance characteristics which are dependent on temperature, typically called the temperature coefficient of resistance or “tempco.” The magnitude and characteristics of these effects varies and is often used in devices such as a resistance temperature detector “RTD”, such as a platinum rtd's, or in positive temperature coefficient “PTC” or negative temperature coefficient “NTC” thermistors.
  • The systems herein can therefore alternatively monitor temperature by using the inherent tempco of the electrode itself as a way of monitoring its temperature and or controlling its impedance and thereby self-limiting its power output and thereby its temperature.
  • FIG. 12 represents an embodiment of a system similar to that of FIG. 6 represented by the resistances of the various elements. The delivery RF lead which runs down catheter is represented as resistance 626 and the electrode is represented by resistance 619. In this embodiment there is an additional conductive element running along the catheter shaft which is a return line represented by resistance 650. In use the leads whose resistances are represented by 626 and 650 may be sourced in parallel when RF is delivered to electrode 619 and addressed separately when used to characterize the resistance and hence temperature of the electrode 619. Alternatively one of them may be used solely for the purpose of monitoring temperature and therefore left open circuited when RF is being delivered. The design of the delivery system and electrode will be such that the impedance 640 of the patient will be orders of magnitude greater then the impedances for the delivery leads 626, 650, and the electrode 619. In one embodiment impedance 619 will be considerably greater than 626 or 650, or in some cases the parallel combination of 626 and 650.
  • In one embodiment the electrode is comprised of a layer of platinum and the temperature of the electrode may be characterized by monitoring the voltage drop across the series resistances 626, 619, 650. This may be done intermittently, interspersed in the delivery of the RF energy. As the electrode heats, its resistance will increase in a well-known and repeatable fashion. As the leads 626 and 650 have lower resistance and will not self-heat appreciable, the change in resistance will by primarily due to the heating of electrode 619 and variation in its resistance. Many other scenarios will be understood to those skilled in the art.
  • An alternate arrangement which relies on the use of a PTC for the electrode relies on the rapid change in resistance of the electrode past a particular set point which is a function of the composition of the electrode. In this configuration the tempco of the electrode is relatively small, for example, below about 40 C but above about 40 C. In this temperature range the tempco rapidly increases thereby limiting delivered power in a voltage-limited RF configuration. Many alternate embodiments will be understood by those skilled in the art.
  • FIG. 13 illustrates an alternative configuration in which a capacitor 648, inductor (not shown), or both may be incorporated in the circuit. In one embodiment the circuit may incorporate only one source lead 621 and the inherent resonance of the circuit which will depend on the varying impedance of the electrode resistance 623.
  • In yet another alternative the tempco associated with a conductive ink such as the ECM CI-1036 may be used. Experimentally the ECM CI-1036 demonstrated a 0.1% increase in impedance per degree over the range of 30 C to 60 C.
  • As described above, devices capable of ablating renal nerves surrounding the renal arteries are useful in treating hypertension. The device disclosed in FIG. 16 is another embodiment of a device adapted for such purpose. The device described herein comprises a bipolar electrode pair disposed on the outer surface of an expandable structure comprised of an inflatable balloon. A bipolar electrode pair provides for both a more controlled burn and a shallower burn than a comparable monopolar electrode. The device is configured for endovascular delivery to a renal artery. Each of the individual electrodes comprising the bipolar set is in turn comprised of a unitary electrode/conductor.
  • Referring to FIG. 16, detailed description of the distal features of an embodiment of the device is as follows. The distal portion of an bipolar RF delivery device 810 includes an expandable section 850 including a balloon, and a catheter shaft section 820 including an inner shaft 830 and an outer shaft 840. The inner lumen of the inner shaft 830 includes a guidewire lumen 822. The annular gap between the inner and outer shafts includes an irrigation lumen 821. The outer shaft 840 also includes an irrigation outflow 812 (e.g., an irrigation port) located near its distal end such that it is disposed within the balloon. A temperature sensor 811 may be located within the balloon 850 and interconnecting leads of the temperature sensor 811 may be routed through the irrigation lumen outflow 812 and irrigation lumen 821.
  • Prior to assembly, a conductive material is deposited on substantially the entire inner shaft 830. A dielectric material is then deposited on the conductive material except at the distal most end of the inner shaft 830. The inner shaft 830 is then fitted within the outer shaft 840 and the two are affixed to one another such that the inner shaft 830 extends beyond the most distal portion of the outer shaft 840 and the balloon 850. The dielectric on the inner shaft 830 is deposited on at least the portions of the surface of the conductor on the inner shaft 830 that would contact irrigation fluid, thus preventing the conductive material on the inner shaft 830 from coming into contact with irrigation fluid. The distal end of the inner shaft 830, which extends distal to the outer shaft 840, is not coated with dielectric. This allows the inner shaft 830 to be in electrical communication with the inner sourced electrode as described below.
  • Next, the outer shaft 840 and balloon 850 are coated with an elastomeric ink, and then, subsequently, by a dielectric as described above. The conductive coating is deposited on the outer shaft 840, all or a portion of the proximal cone 843 of the balloon 850, and on the balloon 850, forming a conductive material that includes an outer sourced spiral electrode 842. This conductive material can be deposited in a unitary manner, as is described above and in the materials incorporated by reference herein. Conductive material is also deposited on the most distal section of the shaft assembly, the distal cone portion 833 of the balloon 850, and the balloon 850, forming a conductive material that includes an inner sourced electrode 832. This conductor can also be formed in a unitary manner. The conductive material that forms the inner sourced electrode can be the same material that is used for the outer sourced electrode. When the distal conductor (which includes the inner sourced electrode 832) is formed, it interfaces electrically with the conductor on the inner shaft 830 that extends distal to the balloon 850. The conductive materials can be selected such that when the conductive materials are deposited, the interface is a single layer of the same material rather than two distinct layers. The conductor and dielectric structures can be fabricated as described above. When used in bipolar mode, energy passes from one spiral electrode 832 or 842, through renal nerve tissue, to the other electrode. The electrodes 832, 842 can be used in a bipolar manner, or each electrode can be used in monopolar mode. Bipolar mode can be used if the tissue burn need not be as deep as may be needed if using a monopolar mode. Bipolar mode generally allows more control in the tissue burn. Additionally or alternatively, the electrodes 832, 842 can be used together as a single monopolar electrode (e.g., by feeding both electrodes with the same frequency and RF energy such that the electrodes appear to be one electrode).
  • In an alternative embodiment, the inner shaft is not coated with a conductor (or dielectric) and, instead, a wire extends through the irrigation lumen, and interfaces the conductor that includes the inner sourced electrode.
  • Although not shown in FIG. 16, irrigation ports as described above can be situated such that they pass through the electrode structures, sit adjacent to the electrode structures such as in the space between them or exterior to the pair, or both.
  • One or more radio opaque markers 813 may be affixed to the outer shaft.
  • While several embodiments of the disclosure have been shown in the drawings and/or discussed herein, it is not intended that the disclosure be limited thereto, as it is intended that the disclosure be as broad in scope as the art will allow and that the specification be read likewise. Therefore, the above description should not be construed as limiting, but merely as exemplifications of particular embodiments. Those skilled in the art will envision other modifications within the scope and spirit of the claims appended hereto.

Claims (22)

1. An expandable energy delivery assembly adapted to deliver electrical energy to tissue, comprising:
an elongate device; and
an expandable portion comprising
an inflatable element, a single helical electrode disposed on the inflatable element, and at least one irrigation aperture within the inflatable element, the inflatable element secured to the elongate device, the single helical electrode making between about 0.5 and about 1.5 revolutions around the inflatable element, and the at least one irrigation aperture adapted to allow fluid to flow from within the inflatable element to outside the inflatable element.
2. The assembly of claim 1 wherein the single helical electrode makes between about 1 and about 1.25 revolutions around the inflatable element.
3. The assembly of claim 1 further comprising a conductive material disposed on the elongate device proximal to the expandable portion to electrically couple the single helical electrode to an electrical energy source.
4. The assembly of claim 3 wherein the conductive material is disposed on substantially the entire elongate device proximal to the expandable portion.
5. The assembly of claim 3 further comprising an insulation material disposed on substantially all of the conductive material on the elongate device.
6-7. (canceled)
8. The assembly of claim 1 wherein the expandable portion comprises a proximal transition section covered with a conductive material that electrically couples the helical electrode and the conductive material on the elongate device.
9. The assembly of claim 8 further comprising an insulation material disposed on the conductive material on the transition shaped section.
10. The assembly of claim 1 wherein the inflatable element is a balloon with a substantially cylindrical section, the single helical electrode disposed on the substantially cylindrical section.
11. The assembly of claim 1 wherein the at least one irrigation aperture is in the inflatable element.
12. The assembly of claim 11 wherein the at least one irrigation apertures is in the helical electrode.
13. The assembly of claim 11 wherein the at least one irrigation aperture is not in the helical electrode.
14. The assembly of claim 11 wherein the at least one irrigation aperture is adjacent the helical electrode.
15-27. (canceled)
28. A method of manufacturing an expandable energy delivery assembly adapted to deliver energy to tissue, comprising:
providing an inflatable element secured to an elongate device;
inflating the inflatable element; and
depositing a conductive material on an exterior surface of the inflatable element to form a single helical electrode making between about 0.5 and about 1.5 revolutions around the inflatable element.
29. The method of claim 28 wherein depositing comprises one selected from the group consisting of vapor deposition, electroplating, electroless plating, pad printing, spraying, and ink jet.
30. The method of claim 28 further comprising applying a mask to the inflatable element before the depositing step.
31-32. (canceled)
33. The method of claim 30 further comprising removing the mask, applying a second mask over the helical electrode, and depositing an insulation material over substantially all of the elongate device proximal to the inflatable element.
34. The method of claim 33 wherein depositing the insulation material comprises depositing the insulation material over a transition section of the inflatable element.
35. The method of claim 33 wherein applying the second mask comprises applying the second mask over an entire intermediate section of the inflatable element.
36-73. (canceled)
US14/348,035 2011-09-30 2012-09-28 Energy delivery device and methods of use Abandoned US20140243821A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US14/348,035 US20140243821A1 (en) 2011-09-30 2012-09-28 Energy delivery device and methods of use

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161541765P 2011-09-30 2011-09-30
US201261593147P 2012-01-31 2012-01-31
PCT/US2012/057967 WO2013049601A2 (en) 2011-09-30 2012-09-28 Energy delivery device and methods of use
US14/348,035 US20140243821A1 (en) 2011-09-30 2012-09-28 Energy delivery device and methods of use

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
PCT/US2012/057967 A-371-Of-International WO2013049601A2 (en) 2008-11-11 2012-09-28 Energy delivery device and methods of use

Related Child Applications (2)

Application Number Title Priority Date Filing Date
US14/391,641 Continuation-In-Part US11376061B2 (en) 2008-11-11 2013-03-15 Energy delivery device and methods of use
US17/188,833 Continuation US20210251681A1 (en) 2011-09-30 2021-03-01 Energy delivery device and methods of use

Publications (1)

Publication Number Publication Date
US20140243821A1 true US20140243821A1 (en) 2014-08-28

Family

ID=47143270

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/348,035 Abandoned US20140243821A1 (en) 2011-09-30 2012-09-28 Energy delivery device and methods of use
US17/188,833 Pending US20210251681A1 (en) 2011-09-30 2021-03-01 Energy delivery device and methods of use

Family Applications After (1)

Application Number Title Priority Date Filing Date
US17/188,833 Pending US20210251681A1 (en) 2011-09-30 2021-03-01 Energy delivery device and methods of use

Country Status (8)

Country Link
US (2) US20140243821A1 (en)
EP (1) EP2760532B1 (en)
JP (2) JP6146923B2 (en)
KR (2) KR20150143881A (en)
CN (2) CN103826694B (en)
CA (1) CA2849123C (en)
ES (1) ES2757682T3 (en)
WO (1) WO2013049601A2 (en)

Cited By (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20150066013A1 (en) * 2008-11-11 2015-03-05 Covidien Lp Energy Delivery Device and Methods of Use
US8986294B2 (en) 2002-04-08 2015-03-24 Medtronic Ardian Luxembourg S.a.rl. Apparatuses for thermally-induced renal neuromodulation
US8998894B2 (en) 2010-10-25 2015-04-07 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods
US9023037B2 (en) 2002-04-08 2015-05-05 Medtronic Ardian Luxembourg S.A.R.L. Balloon catheter apparatus for renal neuromodulation
US9095321B2 (en) 2012-11-21 2015-08-04 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
US9138281B2 (en) 2002-04-08 2015-09-22 Medtronic Ardian Luxembourg S.A.R.L. Methods for bilateral renal neuromodulation via catheter apparatuses having expandable baskets
US9138292B2 (en) 2012-05-11 2015-09-22 Medtronic Ardian Luxembourg S.A.R.L. Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods
US9179974B2 (en) 2013-03-15 2015-11-10 Medtronic Ardian Luxembourg S.A.R.L. Helical push wire electrode
US20150342660A1 (en) * 2014-05-28 2015-12-03 Kyphon SÀRL Cryogenic kyphoplasty instrument and methods of use
US9289255B2 (en) 2002-04-08 2016-03-22 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for renal neuromodulation
US9554848B2 (en) 1999-04-05 2017-01-31 Medtronic, Inc. Ablation catheters and associated systems and methods
US9579149B2 (en) 2014-03-13 2017-02-28 Medtronic Ardian Luxembourg S.A.R.L. Low profile catheter assemblies and associated systems and methods
US9707035B2 (en) 2002-04-08 2017-07-18 Medtronic Ardian Luxembourg S.A.R.L. Methods for catheter-based renal neuromodulation
US20170312022A1 (en) * 2016-04-28 2017-11-02 Biosense Webster (Israel) Ltd. Irrigated balloon catheter with flexible circuit electrode assembly
US20170311893A1 (en) * 2016-04-28 2017-11-02 Biosense Webster (Israel) Ltd. Method of constructing irrigated balloon catheter
US9827040B2 (en) 2002-04-08 2017-11-28 Medtronic Adrian Luxembourg S.a.r.l. Methods and apparatus for intravascularly-induced neuromodulation
US9919144B2 (en) 2011-04-08 2018-03-20 Medtronic Adrian Luxembourg S.a.r.l. Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
EP3291729A4 (en) * 2015-05-07 2018-04-18 Ecom Medical, Inc. Systems and methods for internal ecg acquisition
US10350004B2 (en) 2004-12-09 2019-07-16 Twelve, Inc. Intravascular treatment catheters
US10588682B2 (en) 2011-04-25 2020-03-17 Medtronic Ardian Luxembourg S.A.R.L. Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls
US20200197086A1 (en) * 2013-06-05 2020-06-25 Metavention, Inc. Modulation of targeted nerve fibers
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US10736690B2 (en) 2014-04-24 2020-08-11 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters and associated systems and methods
US10799181B2 (en) 2016-08-13 2020-10-13 Ecom Medical, Inc. Medical devices with layered conductive elements and methods for manufacturing the same
CN112295033A (en) * 2019-07-30 2021-02-02 伯恩森斯韦伯斯特(以色列)有限责任公司 Bubble detector on the proximal end of a catheter with a failsafe mechanism
US11020181B2 (en) 2016-01-07 2021-06-01 Educational Foundation Kyorin Gakuen Infrared denaturing device
US11213678B2 (en) 2013-09-09 2022-01-04 Medtronic Ardian Luxembourg S.A.R.L. Method of manufacturing a medical device for neuromodulation
US11318297B2 (en) 2017-09-21 2022-05-03 Medtronic, Inc. Imaging markers for stimulator leads
US11465171B2 (en) 2017-08-21 2022-10-11 Ecom Medical, Inc. Systems and methods for applying materials to medical devices
USD968422S1 (en) 2019-05-31 2022-11-01 Biosense Webster (Israel) Ltd. Display screen with transitional graphical user interface
USD968421S1 (en) 2019-05-31 2022-11-01 Biosense Webster (Israel) Ltd. Display screen with a graphical user interface
USD969138S1 (en) 2019-05-31 2022-11-08 Biosense Webster (Israel) Ltd. Display screen with a graphical user interface
US11872026B2 (en) 2019-12-04 2024-01-16 Biosense Webster (Israel) Ltd. Catheter contact force sensor
US11957852B2 (en) 2021-12-09 2024-04-16 Biosense Webster (Israel) Ltd. Intravascular balloon with slidable central irrigation tube

Families Citing this family (107)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE202004021942U1 (en) 2003-09-12 2013-05-13 Vessix Vascular, Inc. Selectable eccentric remodeling and / or ablation of atherosclerotic material
US9713730B2 (en) 2004-09-10 2017-07-25 Boston Scientific Scimed, Inc. Apparatus and method for treatment of in-stent restenosis
US9125667B2 (en) 2004-09-10 2015-09-08 Vessix Vascular, Inc. System for inducing desirable temperature effects on body tissue
US8396548B2 (en) 2008-11-14 2013-03-12 Vessix Vascular, Inc. Selective drug delivery in a lumen
US8019435B2 (en) 2006-05-02 2011-09-13 Boston Scientific Scimed, Inc. Control of arterial smooth muscle tone
AU2007310986B2 (en) 2006-10-18 2013-07-04 Boston Scientific Scimed, Inc. Inducing desirable temperature effects on body tissue
AU2007310988B2 (en) 2006-10-18 2013-08-15 Vessix Vascular, Inc. Tuned RF energy and electrical tissue characterization for selective treatment of target tissues
US10987494B2 (en) 2008-11-11 2021-04-27 Covidien Lp Pleated or folded catheter-mounted balloon
US9795442B2 (en) 2008-11-11 2017-10-24 Shifamed Holdings, Llc Ablation catheters
AU2009314133B2 (en) 2008-11-17 2015-12-10 Vessix Vascular, Inc. Selective accumulation of energy with or without knowledge of tissue topography
KR20130108067A (en) 2010-04-09 2013-10-02 베식스 바스큘라 인코포레이티드 Power generating and control apparatus for the treatment of tissue
US9192790B2 (en) 2010-04-14 2015-11-24 Boston Scientific Scimed, Inc. Focused ultrasonic renal denervation
US9655677B2 (en) 2010-05-12 2017-05-23 Shifamed Holdings, Llc Ablation catheters including a balloon and electrodes
US8473067B2 (en) 2010-06-11 2013-06-25 Boston Scientific Scimed, Inc. Renal denervation and stimulation employing wireless vascular energy transfer arrangement
US9463062B2 (en) 2010-07-30 2016-10-11 Boston Scientific Scimed, Inc. Cooled conductive balloon RF catheter for renal nerve ablation
US9084609B2 (en) 2010-07-30 2015-07-21 Boston Scientific Scime, Inc. Spiral balloon catheter for renal nerve ablation
US9358365B2 (en) 2010-07-30 2016-06-07 Boston Scientific Scimed, Inc. Precision electrode movement control for renal nerve ablation
US9155589B2 (en) 2010-07-30 2015-10-13 Boston Scientific Scimed, Inc. Sequential activation RF electrode set for renal nerve ablation
US9408661B2 (en) 2010-07-30 2016-08-09 Patrick A. Haverkost RF electrodes on multiple flexible wires for renal nerve ablation
US9084610B2 (en) 2010-10-21 2015-07-21 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses, systems, and methods for renal neuromodulation
US8974451B2 (en) 2010-10-25 2015-03-10 Boston Scientific Scimed, Inc. Renal nerve ablation using conductive fluid jet and RF energy
US9220558B2 (en) 2010-10-27 2015-12-29 Boston Scientific Scimed, Inc. RF renal denervation catheter with multiple independent electrodes
US9028485B2 (en) 2010-11-15 2015-05-12 Boston Scientific Scimed, Inc. Self-expanding cooling electrode for renal nerve ablation
US9668811B2 (en) 2010-11-16 2017-06-06 Boston Scientific Scimed, Inc. Minimally invasive access for renal nerve ablation
US9089350B2 (en) 2010-11-16 2015-07-28 Boston Scientific Scimed, Inc. Renal denervation catheter with RF electrode and integral contrast dye injection arrangement
US9326751B2 (en) 2010-11-17 2016-05-03 Boston Scientific Scimed, Inc. Catheter guidance of external energy for renal denervation
US9060761B2 (en) 2010-11-18 2015-06-23 Boston Scientific Scime, Inc. Catheter-focused magnetic field induced renal nerve ablation
US9023034B2 (en) 2010-11-22 2015-05-05 Boston Scientific Scimed, Inc. Renal ablation electrode with force-activatable conduction apparatus
US9192435B2 (en) 2010-11-22 2015-11-24 Boston Scientific Scimed, Inc. Renal denervation catheter with cooled RF electrode
US20120157993A1 (en) 2010-12-15 2012-06-21 Jenson Mark L Bipolar Off-Wall Electrode Device for Renal Nerve Ablation
WO2012100095A1 (en) 2011-01-19 2012-07-26 Boston Scientific Scimed, Inc. Guide-compatible large-electrode catheter for renal nerve ablation with reduced arterial injury
AU2012250729B2 (en) 2011-05-03 2016-12-01 Shifamed Holdings, Llc Steerable delivery sheaths
CN103813745B (en) 2011-07-20 2016-06-29 波士顿科学西美德公司 In order to visualize, be directed at and to melt transcutaneous device and the method for nerve
JP6106669B2 (en) 2011-07-22 2017-04-05 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. A neuromodulation system having a neuromodulation element that can be placed in a helical guide
WO2013055826A1 (en) 2011-10-10 2013-04-18 Boston Scientific Scimed, Inc. Medical devices including ablation electrodes
US9420955B2 (en) 2011-10-11 2016-08-23 Boston Scientific Scimed, Inc. Intravascular temperature monitoring system and method
US10085799B2 (en) 2011-10-11 2018-10-02 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US9364284B2 (en) 2011-10-12 2016-06-14 Boston Scientific Scimed, Inc. Method of making an off-wall spacer cage
WO2013058962A1 (en) 2011-10-18 2013-04-25 Boston Scientific Scimed, Inc. Deflectable medical devices
EP2768568B1 (en) 2011-10-18 2020-05-06 Boston Scientific Scimed, Inc. Integrated crossing balloon catheter
EP2775948B1 (en) 2011-11-08 2018-04-04 Boston Scientific Scimed, Inc. Ostial renal nerve ablation
US9119600B2 (en) 2011-11-15 2015-09-01 Boston Scientific Scimed, Inc. Device and methods for renal nerve modulation monitoring
US9119632B2 (en) 2011-11-21 2015-09-01 Boston Scientific Scimed, Inc. Deflectable renal nerve ablation catheter
US9265969B2 (en) 2011-12-21 2016-02-23 Cardiac Pacemakers, Inc. Methods for modulating cell function
WO2013096916A2 (en) 2011-12-23 2013-06-27 Vessix Vascular, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US9433760B2 (en) 2011-12-28 2016-09-06 Boston Scientific Scimed, Inc. Device and methods for nerve modulation using a novel ablation catheter with polymeric ablative elements
US9050106B2 (en) 2011-12-29 2015-06-09 Boston Scientific Scimed, Inc. Off-wall electrode device and methods for nerve modulation
US8961550B2 (en) 2012-04-17 2015-02-24 Indian Wells Medical, Inc. Steerable endoluminal punch
US10660703B2 (en) 2012-05-08 2020-05-26 Boston Scientific Scimed, Inc. Renal nerve modulation devices
US10321946B2 (en) 2012-08-24 2019-06-18 Boston Scientific Scimed, Inc. Renal nerve modulation devices with weeping RF ablation balloons
US9173696B2 (en) 2012-09-17 2015-11-03 Boston Scientific Scimed, Inc. Self-positioning electrode system and method for renal nerve modulation
US10549127B2 (en) 2012-09-21 2020-02-04 Boston Scientific Scimed, Inc. Self-cooling ultrasound ablation catheter
US10398464B2 (en) 2012-09-21 2019-09-03 Boston Scientific Scimed, Inc. System for nerve modulation and innocuous thermal gradient nerve block
CN104869930B (en) 2012-10-10 2020-12-25 波士顿科学国际有限公司 Renal neuromodulation apparatus and methods
US9770593B2 (en) 2012-11-05 2017-09-26 Pythagoras Medical Ltd. Patient selection using a transluminally-applied electric current
CN107334525B (en) 2012-11-05 2019-10-08 毕达哥拉斯医疗有限公司 Controlled tissue ablation
US9956033B2 (en) 2013-03-11 2018-05-01 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9693821B2 (en) 2013-03-11 2017-07-04 Boston Scientific Scimed, Inc. Medical devices for modulating nerves
US9808311B2 (en) 2013-03-13 2017-11-07 Boston Scientific Scimed, Inc. Deflectable medical devices
US20140277313A1 (en) * 2013-03-14 2014-09-18 Biotronik Se & Co. Kg Implantable Electrode
US10265122B2 (en) 2013-03-15 2019-04-23 Boston Scientific Scimed, Inc. Nerve ablation devices and related methods of use
US9297845B2 (en) 2013-03-15 2016-03-29 Boston Scientific Scimed, Inc. Medical devices and methods for treatment of hypertension that utilize impedance compensation
EP2967734B1 (en) 2013-03-15 2019-05-15 Boston Scientific Scimed, Inc. Methods and apparatuses for remodeling tissue of or adjacent to a body passage
US10349824B2 (en) 2013-04-08 2019-07-16 Apama Medical, Inc. Tissue mapping and visualization systems
JP6463731B2 (en) 2013-04-08 2019-02-06 アパマ・メディカル・インコーポレーテッド Imaging system
US10098694B2 (en) 2013-04-08 2018-10-16 Apama Medical, Inc. Tissue ablation and monitoring thereof
JP6066318B2 (en) * 2013-06-06 2017-01-25 日本ライフライン株式会社 Electrode catheter system
CN105473092B (en) 2013-06-21 2019-05-17 波士顿科学国际有限公司 The medical instrument for renal nerve ablation with rotatable shaft
WO2014205404A1 (en) * 2013-06-21 2014-12-24 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
EP3010437A1 (en) 2013-06-21 2016-04-27 Boston Scientific Scimed, Inc. Renal denervation balloon catheter with ride along electrode support
US9707036B2 (en) 2013-06-25 2017-07-18 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation using localized indifferent electrodes
WO2015002787A1 (en) 2013-07-01 2015-01-08 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
WO2015006480A1 (en) 2013-07-11 2015-01-15 Boston Scientific Scimed, Inc. Devices and methods for nerve modulation
EP3019106A1 (en) 2013-07-11 2016-05-18 Boston Scientific Scimed, Inc. Medical device with stretchable electrode assemblies
WO2015010074A1 (en) 2013-07-19 2015-01-22 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon
WO2015013205A1 (en) 2013-07-22 2015-01-29 Boston Scientific Scimed, Inc. Medical devices for renal nerve ablation
US10695124B2 (en) 2013-07-22 2020-06-30 Boston Scientific Scimed, Inc. Renal nerve ablation catheter having twist balloon
WO2015027096A1 (en) 2013-08-22 2015-02-26 Boston Scientific Scimed, Inc. Flexible circuit having improved adhesion to a renal nerve modulation balloon
EP3041425B1 (en) 2013-09-04 2022-04-13 Boston Scientific Scimed, Inc. Radio frequency (rf) balloon catheter having flushing and cooling capability
WO2015038947A1 (en) 2013-09-13 2015-03-19 Boston Scientific Scimed, Inc. Ablation balloon with vapor deposited cover layer
EP2848225A1 (en) * 2013-09-13 2015-03-18 Covidien LP A pleated or folded catheter-mounted balloon
US11246654B2 (en) 2013-10-14 2022-02-15 Boston Scientific Scimed, Inc. Flexible renal nerve ablation devices and related methods of use and manufacture
CN105592778B (en) 2013-10-14 2019-07-23 波士顿科学医学有限公司 High-resolution cardiac mapping electrod-array conduit
AU2014334574B2 (en) 2013-10-15 2017-07-06 Boston Scientific Scimed, Inc. Medical device balloon
US9770606B2 (en) 2013-10-15 2017-09-26 Boston Scientific Scimed, Inc. Ultrasound ablation catheter with cooling infusion and centering basket
CN105636538B (en) 2013-10-18 2019-01-15 波士顿科学国际有限公司 Foley's tube with flexible wire and its correlation technique for using and manufacturing
CN105658163B (en) 2013-10-25 2020-08-18 波士顿科学国际有限公司 Embedded thermocouple in denervation flexible circuit
WO2015074046A1 (en) * 2013-11-18 2015-05-21 Jeremy Stigall Treatment catheter including therapeutic energy delivery
WO2015103617A1 (en) 2014-01-06 2015-07-09 Boston Scientific Scimed, Inc. Tear resistant flex circuit assembly
JP6325121B2 (en) 2014-02-04 2018-05-16 ボストン サイエンティフィック サイムド,インコーポレイテッドBoston Scientific Scimed,Inc. Alternative placement of temperature sensors on bipolar electrodes
US11000679B2 (en) 2014-02-04 2021-05-11 Boston Scientific Scimed, Inc. Balloon protection and rewrapping devices and related methods of use
EP3139853B1 (en) 2014-05-07 2018-12-19 Pythagoras Medical Ltd. Controlled tissue ablation apparatus
US9597142B2 (en) * 2014-07-24 2017-03-21 Arthrocare Corporation Method and system related to electrosurgical procedures
CN107405077B (en) 2015-02-18 2023-10-20 莱彻韦斯科勒公司 Radiofrequency guidewire with controlled plasma generation and method of use thereof
EP3274037B1 (en) 2015-03-27 2021-11-03 Kalila Medical, Inc. Steerable medical devices
WO2016172706A1 (en) 2015-04-24 2016-10-27 Shifamed Holdings, Llc Steerable medical devices, systems, and methods of use
US10383685B2 (en) 2015-05-07 2019-08-20 Pythagoras Medical Ltd. Techniques for use with nerve tissue
CN107206218B (en) * 2015-05-15 2021-06-25 尼普洛株式会社 Balloon catheter
EP3373794B1 (en) 2015-11-09 2022-01-05 Kalila Medical, Inc. Steering assemblies for medical devices
CN108348146A (en) 2015-11-16 2018-07-31 阿帕玛医疗公司 Energy transmission device
EP3457975A2 (en) 2016-05-18 2019-03-27 Pythagoras Medical Ltd. Helical catheter
KR20190062419A (en) 2016-10-04 2019-06-05 아벤트, 인크. The cooled RF probe
EP3600551A1 (en) * 2017-03-28 2020-02-05 Emblation Limited Stenosis treatment
US11478298B2 (en) 2018-01-24 2022-10-25 Medtronic Ardian Luxembourg S.A.R.L. Controlled irrigation for neuromodulation systems and associated methods
JPWO2022259438A1 (en) * 2021-06-09 2022-12-15
JP7410199B2 (en) 2022-02-28 2024-01-09 日本ライフライン株式会社 Balloon electrode catheter
JP7410198B2 (en) 2022-02-28 2024-01-09 日本ライフライン株式会社 Balloon electrode catheter

Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6091995A (en) * 1996-11-08 2000-07-18 Surx, Inc. Devices, methods, and systems for shrinking tissues
US6123718A (en) * 1998-11-02 2000-09-26 Polymerex Medical Corp. Balloon catheter
US6488673B1 (en) * 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US20030009165A1 (en) * 1998-01-14 2003-01-09 Curon Medical, Inc. GERD treatment apparatus and method
US20030050637A1 (en) * 1997-07-08 2003-03-13 Maguire Mark A. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US20040167509A1 (en) * 2003-02-24 2004-08-26 Scimed Life Systems, Inc. Probes having helical and loop shaped inflatable therapeutic elements
US20050171525A1 (en) * 2004-02-02 2005-08-04 Rioux Robert J. System and method for performing ablation using a balloon
US20070203549A1 (en) * 2005-12-29 2007-08-30 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US20070287994A1 (en) * 2006-06-12 2007-12-13 Pankaj Amrit Patel Endoscopically Introducible Expandable Bipolar Probe
US20090247933A1 (en) * 2008-03-27 2009-10-01 The Regents Of The University Of California; Angiodynamics, Inc. Balloon catheter method for reducing restenosis via irreversible electroporation
US20100160906A1 (en) * 2008-12-23 2010-06-24 Asthmatx, Inc. Expandable energy delivery devices having flexible conductive elements and associated systems and methods
US20110257647A1 (en) * 2008-05-09 2011-10-20 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US20120029511A1 (en) * 2010-07-30 2012-02-02 Scott Smith Cooled Conductive Balloon RF Catheter for Renal Nerve Ablation
US20120071870A1 (en) * 2008-11-11 2012-03-22 Amr Salahieh Low Profile Electrode Assembly
US20120130363A1 (en) * 2010-11-23 2012-05-24 Isaac Kim Inverted balloon rf ablation catheter and method
US20120310233A1 (en) * 2009-11-11 2012-12-06 Innovative Pulmonary Solutions, Inc Systems, apparatuses, and methods for treating tissue and controlling stenosis
US20130204068A1 (en) * 2011-12-15 2013-08-08 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and Methods For Treating Pulmonary Hypertension
US20130253622A1 (en) * 2010-12-01 2013-09-26 Michael D. Hooven Method and apparatus for remodeling/profiling a tissue lumen, particularly in the urethral lumen in the prostate gland
US20130296853A1 (en) * 2010-12-21 2013-11-07 Terumo Kabushiki Kaisha Balloon catheter and electrification system
US20150025525A1 (en) * 2013-07-19 2015-01-22 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1995010319A1 (en) * 1993-10-15 1995-04-20 Ep Technologies, Inc. Electrodes for creating lesions in body tissue
US6009877A (en) * 1994-06-24 2000-01-04 Edwards; Stuart D. Method for treating a sphincter
US6409722B1 (en) * 1998-07-07 2002-06-25 Medtronic, Inc. Apparatus and method for creating, maintaining, and controlling a virtual electrode used for the ablation of tissue
US6958059B2 (en) * 1996-05-20 2005-10-25 Medtronic Ave, Inc. Methods and apparatuses for drug delivery to an intravascular occlusion
US6500174B1 (en) * 1997-07-08 2002-12-31 Atrionix, Inc. Circumferential ablation device assembly and methods of use and manufacture providing an ablative circumferential band along an expandable member
US6117101A (en) * 1997-07-08 2000-09-12 The Regents Of The University Of California Circumferential ablation device assembly
US6522930B1 (en) * 1998-05-06 2003-02-18 Atrionix, Inc. Irrigated ablation device assembly
ES2228083T3 (en) * 1998-08-14 2005-04-01 K.U. LEUVEN RESEARCH & DEVELOPMENT COOLED HUMID ELECTRODE.
JP2000140118A (en) * 1998-11-09 2000-05-23 Olympus Optical Co Ltd High frequency treatment implement
US7653438B2 (en) * 2002-04-08 2010-01-26 Ardian, Inc. Methods and apparatus for renal neuromodulation
US8092549B2 (en) * 2004-09-24 2012-01-10 The Invention Science Fund I, Llc Ciliated stent-like-system
US8140170B2 (en) * 2005-09-12 2012-03-20 The Cleveland Clinic Foundation Method and apparatus for renal neuromodulation
US8128617B2 (en) * 2008-05-27 2012-03-06 Boston Scientific Scimed, Inc. Electrical mapping and cryo ablating with a balloon catheter
EP3173043A1 (en) * 2008-11-11 2017-05-31 Shifamed Holdings, LLC Low profile electrode assembly
EP3482709B1 (en) * 2010-04-06 2021-07-07 Nuvaira, Inc. System for pulmonary treatment
WO2011130534A2 (en) * 2010-04-14 2011-10-20 Boston Scientific Scimed, Inc. Renal artery denervation apparatus employing helical shaping arrangement
US9241752B2 (en) * 2012-04-27 2016-01-26 Medtronic Ardian Luxembourg S.A.R.L. Shafts with pressure relief in cryotherapeutic catheters and associated devices, systems, and methods

Patent Citations (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6091995A (en) * 1996-11-08 2000-07-18 Surx, Inc. Devices, methods, and systems for shrinking tissues
US6488673B1 (en) * 1997-04-07 2002-12-03 Broncus Technologies, Inc. Method of increasing gas exchange of a lung
US20030050637A1 (en) * 1997-07-08 2003-03-13 Maguire Mark A. Tissue ablation device assembly and method for electrically isolating a pulmonary vein ostium from an atrial wall
US20030009165A1 (en) * 1998-01-14 2003-01-09 Curon Medical, Inc. GERD treatment apparatus and method
US6123718A (en) * 1998-11-02 2000-09-26 Polymerex Medical Corp. Balloon catheter
US20040167509A1 (en) * 2003-02-24 2004-08-26 Scimed Life Systems, Inc. Probes having helical and loop shaped inflatable therapeutic elements
US20050171525A1 (en) * 2004-02-02 2005-08-04 Rioux Robert J. System and method for performing ablation using a balloon
US20070203549A1 (en) * 2005-12-29 2007-08-30 Ardian, Inc. Methods and apparatus for pulsed electric field neuromodulation via an intra-to-extravascular approach
US20070287994A1 (en) * 2006-06-12 2007-12-13 Pankaj Amrit Patel Endoscopically Introducible Expandable Bipolar Probe
US20090247933A1 (en) * 2008-03-27 2009-10-01 The Regents Of The University Of California; Angiodynamics, Inc. Balloon catheter method for reducing restenosis via irreversible electroporation
US20110257647A1 (en) * 2008-05-09 2011-10-20 Innovative Pulmonary Solutions, Inc. Systems, assemblies, and methods for treating a bronchial tree
US20120071870A1 (en) * 2008-11-11 2012-03-22 Amr Salahieh Low Profile Electrode Assembly
US20100160906A1 (en) * 2008-12-23 2010-06-24 Asthmatx, Inc. Expandable energy delivery devices having flexible conductive elements and associated systems and methods
US20120310233A1 (en) * 2009-11-11 2012-12-06 Innovative Pulmonary Solutions, Inc Systems, apparatuses, and methods for treating tissue and controlling stenosis
US20120029511A1 (en) * 2010-07-30 2012-02-02 Scott Smith Cooled Conductive Balloon RF Catheter for Renal Nerve Ablation
US20120130363A1 (en) * 2010-11-23 2012-05-24 Isaac Kim Inverted balloon rf ablation catheter and method
US20130253622A1 (en) * 2010-12-01 2013-09-26 Michael D. Hooven Method and apparatus for remodeling/profiling a tissue lumen, particularly in the urethral lumen in the prostate gland
US20130296853A1 (en) * 2010-12-21 2013-11-07 Terumo Kabushiki Kaisha Balloon catheter and electrification system
US20130204068A1 (en) * 2011-12-15 2013-08-08 The Board Of Trustees Of The Leland Stanford Junior University Apparatus and Methods For Treating Pulmonary Hypertension
US20150025525A1 (en) * 2013-07-19 2015-01-22 Boston Scientific Scimed, Inc. Spiral bipolar electrode renal denervation balloon

Cited By (64)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9554848B2 (en) 1999-04-05 2017-01-31 Medtronic, Inc. Ablation catheters and associated systems and methods
US10105180B2 (en) 2002-04-08 2018-10-23 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravascularly-induced neuromodulation
US10420606B2 (en) 2002-04-08 2019-09-24 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for performing a non-continuous circumferential treatment of a body lumen
US9023037B2 (en) 2002-04-08 2015-05-05 Medtronic Ardian Luxembourg S.A.R.L. Balloon catheter apparatus for renal neuromodulation
US10376311B2 (en) 2002-04-08 2019-08-13 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for intravascularly-induced neuromodulation
US9138281B2 (en) 2002-04-08 2015-09-22 Medtronic Ardian Luxembourg S.A.R.L. Methods for bilateral renal neuromodulation via catheter apparatuses having expandable baskets
US9675413B2 (en) 2002-04-08 2017-06-13 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for renal neuromodulation
US9827040B2 (en) 2002-04-08 2017-11-28 Medtronic Adrian Luxembourg S.a.r.l. Methods and apparatus for intravascularly-induced neuromodulation
US9827041B2 (en) 2002-04-08 2017-11-28 Medtronic Ardian Luxembourg S.A.R.L. Balloon catheter apparatuses for renal denervation
US9289255B2 (en) 2002-04-08 2016-03-22 Medtronic Ardian Luxembourg S.A.R.L. Methods and apparatus for renal neuromodulation
US9757193B2 (en) 2002-04-08 2017-09-12 Medtronic Ardian Luxembourg S.A.R.L. Balloon catheter apparatus for renal neuromodulation
US8986294B2 (en) 2002-04-08 2015-03-24 Medtronic Ardian Luxembourg S.a.rl. Apparatuses for thermally-induced renal neuromodulation
US9707035B2 (en) 2002-04-08 2017-07-18 Medtronic Ardian Luxembourg S.A.R.L. Methods for catheter-based renal neuromodulation
US11272982B2 (en) 2004-12-09 2022-03-15 Twelve, Inc. Intravascular treatment catheters
US10350004B2 (en) 2004-12-09 2019-07-16 Twelve, Inc. Intravascular treatment catheters
US11376061B2 (en) * 2008-11-11 2022-07-05 Covidien Lp Energy delivery device and methods of use
US20150066013A1 (en) * 2008-11-11 2015-03-05 Covidien Lp Energy Delivery Device and Methods of Use
US11116572B2 (en) 2010-10-25 2021-09-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods
US8998894B2 (en) 2010-10-25 2015-04-07 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods
US10076382B2 (en) 2010-10-25 2018-09-18 Medtronic Ardian Luxembourg S.A.R.L. Catheter apparatuses having multi-electrode arrays for renal neuromodulation and associated systems and methods
US9919144B2 (en) 2011-04-08 2018-03-20 Medtronic Adrian Luxembourg S.a.r.l. Iontophoresis drug delivery system and method for denervation of the renal sympathetic nerve and iontophoretic drug delivery
US10588682B2 (en) 2011-04-25 2020-03-17 Medtronic Ardian Luxembourg S.A.R.L. Apparatus and methods related to constrained deployment of cryogenic balloons for limited cryogenic ablation of vessel walls
US10512504B2 (en) 2012-05-11 2019-12-24 Medtronic Ardian Luxembourg S.A.R.L. Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods
US9452017B2 (en) 2012-05-11 2016-09-27 Medtronic Ardian Luxembourg S.A.R.L. Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods
US9855096B2 (en) 2012-05-11 2018-01-02 Medtronic Ardian Luxembourg S.A.R.L. Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods
US9138292B2 (en) 2012-05-11 2015-09-22 Medtronic Ardian Luxembourg S.A.R.L. Multi-electrode catheter assemblies for renal neuromodulation and associated systems and methods
US9095321B2 (en) 2012-11-21 2015-08-04 Medtronic Ardian Luxembourg S.A.R.L. Cryotherapeutic devices having integral multi-helical balloons and methods of making the same
US10792098B2 (en) 2013-03-15 2020-10-06 Medtronic Ardian Luxembourg S.A.R.L. Helical push wire electrode
US9888961B2 (en) 2013-03-15 2018-02-13 Medtronic Ardian Luxembourg S.A.R.L. Helical push wire electrode
US9179974B2 (en) 2013-03-15 2015-11-10 Medtronic Ardian Luxembourg S.A.R.L. Helical push wire electrode
US20200197086A1 (en) * 2013-06-05 2020-06-25 Metavention, Inc. Modulation of targeted nerve fibers
US11213678B2 (en) 2013-09-09 2022-01-04 Medtronic Ardian Luxembourg S.A.R.L. Method of manufacturing a medical device for neuromodulation
US9579149B2 (en) 2014-03-13 2017-02-28 Medtronic Ardian Luxembourg S.A.R.L. Low profile catheter assemblies and associated systems and methods
US11464563B2 (en) 2014-04-24 2022-10-11 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters and associated systems and methods
US10736690B2 (en) 2014-04-24 2020-08-11 Medtronic Ardian Luxembourg S.A.R.L. Neuromodulation catheters and associated systems and methods
US10709490B2 (en) 2014-05-07 2020-07-14 Medtronic Ardian Luxembourg S.A.R.L. Catheter assemblies comprising a direct heating element for renal neuromodulation and associated systems and methods
US20150342660A1 (en) * 2014-05-28 2015-12-03 Kyphon SÀRL Cryogenic kyphoplasty instrument and methods of use
US9936997B2 (en) * 2014-05-28 2018-04-10 Kyphon SÀRL Cryogenic kyphoplasty instrument and methods of use
US20210219920A1 (en) * 2015-05-07 2021-07-22 Ecom Medical, Inc. Systems and methods for internal ecg acquisition
EP3750477A1 (en) 2015-05-07 2020-12-16 Ecom Medical, Inc. Systems and method for fabricating invasive ecg probe
EP3291729A4 (en) * 2015-05-07 2018-04-18 Ecom Medical, Inc. Systems and methods for internal ecg acquisition
US20190320983A1 (en) * 2015-05-07 2019-10-24 Ecom Medical, Inc. Method and apparatus for applying a tracing to an expandable device
US10993667B2 (en) * 2015-05-07 2021-05-04 Ecom Medical, Inc. Method and apparatus for applying a tracing to an expandable device
US11020181B2 (en) 2016-01-07 2021-06-01 Educational Foundation Kyorin Gakuen Infrared denaturing device
US10660700B2 (en) * 2016-04-28 2020-05-26 Biosense Webster (Israel) Ltd. Irrigated balloon catheter with flexible circuit electrode assembly
US10638976B2 (en) * 2016-04-28 2020-05-05 Biosense Webster (Israel) Ltd Method of constructing irrigated balloon catheter
US10653480B2 (en) * 2016-04-28 2020-05-19 Biosense Webster (Israel) Ltd. Method for constructing irrigated balloon catheter with flexible circuit electrode assembly
CN107307904A (en) * 2016-04-28 2017-11-03 韦伯斯特生物官能(以色列)有限公司 Filling type foley's tube with flexible circuit electrode assemblie
US20170311893A1 (en) * 2016-04-28 2017-11-02 Biosense Webster (Israel) Ltd. Method of constructing irrigated balloon catheter
US20170311829A1 (en) * 2016-04-28 2017-11-02 Biosense Webster (Israel) Ltd. Methods for constructing irrigated balloon catheter with flexible circuit electrode assembly
US20170312022A1 (en) * 2016-04-28 2017-11-02 Biosense Webster (Israel) Ltd. Irrigated balloon catheter with flexible circuit electrode assembly
US10799181B2 (en) 2016-08-13 2020-10-13 Ecom Medical, Inc. Medical devices with layered conductive elements and methods for manufacturing the same
US11375953B2 (en) 2016-08-13 2022-07-05 Ecom Medical, Inc. Medical devices with layered conductive elements and methods for manufacturing the same
US11794207B2 (en) 2017-08-21 2023-10-24 Ecom Medical, Inc. Systems and methods for applying materials to medical devices
US11465171B2 (en) 2017-08-21 2022-10-11 Ecom Medical, Inc. Systems and methods for applying materials to medical devices
US11318297B2 (en) 2017-09-21 2022-05-03 Medtronic, Inc. Imaging markers for stimulator leads
USD968422S1 (en) 2019-05-31 2022-11-01 Biosense Webster (Israel) Ltd. Display screen with transitional graphical user interface
USD968421S1 (en) 2019-05-31 2022-11-01 Biosense Webster (Israel) Ltd. Display screen with a graphical user interface
USD969138S1 (en) 2019-05-31 2022-11-08 Biosense Webster (Israel) Ltd. Display screen with a graphical user interface
EP3771475A1 (en) * 2019-07-30 2021-02-03 Biosense Webster (Israel) Ltd Bubble detector on proximal end of catheter with fail-safe mechanism
US11737821B2 (en) 2019-07-30 2023-08-29 Biosense Webster (Israel) Ltd. Bubble detector on proximal end of catheter with fail-safe mechanism
CN112295033A (en) * 2019-07-30 2021-02-02 伯恩森斯韦伯斯特(以色列)有限责任公司 Bubble detector on the proximal end of a catheter with a failsafe mechanism
US11872026B2 (en) 2019-12-04 2024-01-16 Biosense Webster (Israel) Ltd. Catheter contact force sensor
US11957852B2 (en) 2021-12-09 2024-04-16 Biosense Webster (Israel) Ltd. Intravascular balloon with slidable central irrigation tube

Also Published As

Publication number Publication date
JP2014531935A (en) 2014-12-04
CA2849123C (en) 2017-02-21
WO2013049601A3 (en) 2013-07-11
KR20150143881A (en) 2015-12-23
EP2760532B1 (en) 2019-08-28
ES2757682T3 (en) 2020-04-29
CN103826694B (en) 2017-03-22
CN103826694A (en) 2014-05-28
CN106823131B (en) 2019-12-20
WO2013049601A2 (en) 2013-04-04
JP6146923B2 (en) 2017-06-14
KR20140053377A (en) 2014-05-07
CA2849123A1 (en) 2013-04-04
CN106823131A (en) 2017-06-13
EP2760532A2 (en) 2014-08-06
JP2016010729A (en) 2016-01-21
US20210251681A1 (en) 2021-08-19

Similar Documents

Publication Publication Date Title
US20210251681A1 (en) Energy delivery device and methods of use
US11376061B2 (en) Energy delivery device and methods of use
US20230355863A1 (en) Energy delivery device and methods of use
US20150105659A1 (en) Energy delivery device and methods of use
WO2013154775A1 (en) Energy delivery device and methods of manufacturing
US20140018794A1 (en) Off-wall electrode devices and methods for nerve modulation
US20130274731A1 (en) Helical tubing devices and methods for fluid renal nerve modulation
EP3041425B1 (en) Radio frequency (rf) balloon catheter having flushing and cooling capability
US9707036B2 (en) Devices and methods for nerve modulation using localized indifferent electrodes
CN107019554B (en) Temperature controlled short duration ablation
JP7395663B2 (en) Temperature-controlled short-term ablation using multiple electrodes
JP6797702B2 (en) Temperature-controlled short-time ablation
JP2016524949A (en) Medical device for renal nerve ablation having a rotatable shaft
CN107019553B (en) Temperature controlled short duration ablation
JP2021166802A (en) Temperature controlled short duration ablation

Legal Events

Date Code Title Description
AS Assignment

Owner name: SHIFAMED HOLDINGS, LLC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SHIFAMED, LLC;REEL/FRAME:043621/0505

Effective date: 20111129

Owner name: SHIFAMED, LLC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SALAHIEH, AMR;LEPAK, JONAH;LEUNG, EMMA;AND OTHERS;SIGNING DATES FROM 20111004 TO 20111007;REEL/FRAME:043621/0393

Owner name: MAYA MEDICAL, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SHIFAMED HOLDINGS, LLC;REEL/FRAME:043621/0666

Effective date: 20120419

Owner name: SHIFAMED HOLDINGS, LLC, CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:SALAHIEH, AMR;SAUL, TOM;SIGNING DATES FROM 20120131 TO 20120210;REEL/FRAME:043621/0848

Owner name: COVIDIEN LP, MASSACHUSETTS

Free format text: MERGER;ASSIGNOR:MAYA MEDICAL LLC;REEL/FRAME:043621/0807

Effective date: 20121227

Owner name: MAYA MEDICAL, INC., CALIFORNIA

Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNOR:SHIFAMED HOLDINGS, LLC;REEL/FRAME:043621/0907

Effective date: 20120419

Owner name: MAYA MEDICAL LLC, CALIFORNIA

Free format text: CERTIFICATE OF CONVERSION;ASSIGNOR:MAYA MEDICAL, INC.;REEL/FRAME:043899/0919

Effective date: 20120627

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: ADVISORY ACTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION